0dfd0279-ff17-4ea9-89be-9803c71bab44_672_10.jpg b"(570 9pen th pack. Pushtabet through from athr sid. Continus taking one tablet sach day 35 your doctor prescribes. 000000 000000 280 tablet lmbm_xlc_a' mg per table Qo000 0 0o00000\xc2\xab0 Imbruvica- 280 mg per tablet (brutinibl ssies"
0dfd0279-ff17-4ea9-89be-9803c71bab44_672_16.jpg N/A
0dfd0279-ff17-4ea9-89be-9803c71bab44_672_6.jpg b'ooooooo \xef\xac\x82ooooooo S G e W Imboruvicar 140 mg per tabie OOOOOOO OOOOOOO DayB_ DayS_ Dayl0 Oyl Day2_ Days_ DayW Day22___Day2s__ Day24__Day%5__ Day2%___ Day2l__ Day2s__'
0dfd0279-ff17-4ea9-89be-9803c71bab44_672_7.jpg b'Fifp open the pack.Push tablet though from other side. \xe2\x80\x98Continue aking one tablet ach day 25 your doctor prescribes. M) xS O S ok o Red el WA Yy WY Y o Y Xad Ad N et Nt Imbruvica\xe2\x80\x99 10 tablet (ibrutinib) s Rk O O 5 N O QOO Imbruvica\xc2\xae 140 mg per tablet (ibrtinib) s O O -~ A Y st sseRel'
0dfd0279-ff17-4ea9-89be-9803c71bab44_672_8.jpg b"NDG 5706228028 Imbruvica\xc2\xae (ibrutinib) tavlets ot coarstno 20 \xe2\x80\x98Wallt card contains 28 tablets b - Liftto open harmacyclics* anssen L REpamayCles panssen J Imbruvica: 280 mg R L o ale +Toko IMBRUVIGAS abet by mouih, a about hesame tmo eachday,with a giass of water 28 Tablets \xc2\xab Swallow the tblet whoe. Do notcu, crush o chew th ablet + 00 ot st taking IMBRUVICA\xc2\xae without aking o your doctr ettt s WA oo ernong o RS +1tyou miss a dose of IMBRUVICA, take it as soon s you 5 Temermber n the same day Qpharmacyclics' ey g janssen ' STEP 2: While pressing \xe2\x80\x98button, pull card from sieeve at purple dot 'O CLOSE: Fold card and push back Into carton firmly until locked. POt T e qgrarmeeyicr ) Dosage: Sesproscrbing information. Keop outof th reach of shdran. Acivo rgrdiontmads i Crina. S ceccmpanying st e dosage normation. Stors batwean 20 and 25 B8 and 7P excurscns prite batwsen 16 nd 30C: T a5 For morsnfrmetion abcut IMBRUVICAT,call 1-877-677-3538 vt wwoe MBRUVICA.com Imbruvica\xc2\xae 280 mg (ibrutini) ses NDG 57062.250-25 GTIN O0s570E2280286 e o = wor \xc2\xbb.m'!%mm. i, o Roemzsoeet |"
0dfd0279-ff17-4ea9-89be-9803c71bab44_672_9.jpg b"Doyl Dy2__ Day3__ Dw4__ DS Dws__ D7 D15 Day\xc2\xa5__ Dy Dayte___Dayis___oay20 AT 0000000 'gWOOOOOOO Start dosing on Day 1. Take one tablet, once a day. lmb\xef\xac\x82Mca 280 mg per tablet 0000000 ([lOO0D00O0D Day8__ Dayo_ Daylo__ Dayll__ Day__ DayB__ DayM___ D3y2_ Day23_ Day24_ Day2s__ Dy DayZl_ DB"
13bb8267-1cab-43e5-acae-55a4d957630a_661_6.jpg b"Doyl Dy2__ Day3__ Dw4__ DS Dws__ D7 D15 Day\xc2\xa5__ Dy Dayte___Dayis___oay20 AT 0000000 'gWOOOOOOO Start dosing on Day 1. Take one tablet, once a day. lmb\xef\xac\x82Mca 280 mg per tablet 0000000 ([lOO0D00O0D Day8__ Dayo_ Daylo__ Dayll__ Day__ DayB__ DayM___ D3y2_ Day23_ Day24_ Day2s__ Dy DayZl_ DB"
159cb0cb-4b27-4a1c-8ad4-dc93604c79c7_94_6.jpg b'Bui o asn el SpUOIUROIDAH uLpop Bui o} asn el SpuOjUoOIPAH uLpopI Bu o} a5 el SPUGIUOOIDAH ulpopy i e 1 < S g 5 \xc2\xa3 BoEs Midodrine Hydrochioride Tehiel, USP 10 mg y Midodrine Hydrochloride 52 e e B 10 mg Midodrine Nydrochorde 5 g 10 mg ='
1e6d2c80-fbc8-444e-bdd3-6a91fe1b95bd_269_6.jpg b'Each film coated tablet contains: Amitriptyline Hydrochloride USP 150 mg Usual Dosage: See package insert. Store at 20\xc2\xb0 to 25\xc2\xb0C (68\xc2\xb0 to 77\xc2\xb0F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213. INDIA Mfg. Lic. No.: G/25/1883 noc 16720-17617 Amitriptyline Hydrochloride Tablets USP Rx Only PHARMACIST: Dispense the enclosed Medication Guide to each patient. | ,lll]l] Tablets I occord l T Keep area blank & vaish free for overcoding Lot and EXP & Data matrix 50x 30 mm 5127430713970 INLO%6'
205be197-5ad5-4849-bc78-5fda9927b531_959_6.jpg b'GTIN 0368308475471 L NDC 68308-475-47 I Oxycodone and Acetaminophen Tablets, USP O Multiple strengths. Do not dispense [y RxOnly 100 (10x10) unit-dose tablets Each ablet contains: Gryeodone O, U5, 75 mgt Acetaminaphen, USP . s mg 575 mg cupeodone HEI & 6quiaiont o 67338 g of foass SR, e e acampanyog Medication Guide to each patient = e T o S e oA o o 7 e 5 o e T g pmohenies TR it R ons BINGIRN IS, e T e rsae St (@ O s T'
205be197-5ad5-4849-bc78-5fda9927b531_959_7.jpg b'(GTIN 00368308480475 3 Wl58308"4804 7! NDC 68308-480-47 Oxycodone and Acetammuphen Tablets, USP unless the strength is state Eaony 100 (10x10) unitdose tablets Each tabet conine: Gycodone HCl Us?. e 10 Acataminopher, UsP g oy oo i G 1 8567 mgof [ARMACIST:Dispense the accompanying Medication Guide o each patint USUAL DOSAGE See package msert fo complte prescrioing nformtion, ETORAGE Store at 20t 25\xc2\xb0C (68" 10 777 see UsP Conroled foom Temperature] Keep tabiets i box o protec rom ght. Protect from mosture. Thisproduct s potected wit sealed blstr s Dot use fatyareton o broken. This unkdose package s not chidesisant: I dispensed fof outpatentuse a chidesisant Conthiner showid b use, EA ORDER FORM REQUIRED. Manfacured by: Wayne Pharma Greeniie NC 27250 10071 ouzo17'
21628112-0c47-11df-95b3-498d55d89593_767_6.jpg b'", IRy 3 50458-645-65 1 0L, S\xc2\xb0 powiew \xe2\x80\x980 Jeogo pue*, ui 7, 5% pax ey \xe2\x80\x9cApo ajnsdea anibeco ey uy Sa194dS G40 C) N RS RIPRYD 10 432440 10 doay aysou woy 109104d *(oLL) 452 MOJRG 10 12 B10IS \xe2\x80\x9caueIIC IR \xe2\x82\xac | asuadsi( | \xe2\x80\x9caimesay] Jonpoid| | Buruecucoa ss \xe2\x80\x98wopenwoju Buguasasd sego pue afesop 1o 223 gss g8 8 SES S mm& @ 7 N z<s w \xe2\x82\xac, 09 m@mm \xc2\xa9 a5 g2 Q 2@ Eigf \xc2\xa7 o o o O < 2 3 g 9 . | = > 3 - \xc2\xa7 [ X 3. O02a & S0 ] | oL s 000 \xe2\x80\x9c- 09580 I AL nl.m u\'sfeapnaceLg uessuer 1o} By 8100k 0N | T oy uassuer < 0 |'
258e1602-a3cf-4ccc-ca80-73dbbfb812ff_133_10.jpg b'g (omgadestones et (S} Rorty PREMARIN\'0.625 s sepsuspinny bugz90. NRIVIWNR PREMARIN0.625 mg {omaedxtoges e 59 FREMAGIN o\xc3\xa92em Each tablet conain 0,625 g of conpgated estogens, USP. J st Dosage: e endose formatn. PREMARIN\'0.625ng | " o g e U | \' \\ | PREMARIN\xc2\xae {conjgated esrogens ablets, USP) 0.625 mg'
258e1602-a3cf-4ccc-ca80-73dbbfb812ff_133_16.jpg b'mssiepin) NRIVWTId mezL R /'
258e1602-a3cf-4ccc-ca80-73dbbfb812ff_133_6.jpg b'Dispenser Include \xe2\x80\x9cInformation forthe Patient\xe2\x80\x9d leaflet wth each prescription dispensed. Store at 20-25\xc2\xb0C (68-77\xc2\xb0F); excursions permitted to 16-30\xc2\xb0C (59-86\xc2\xb0F). [See USP Controlled Room Temperature] Dispense in tight (USP) child-resistant containers Each tablet contains 0.625 mg of conjugated estrogens, USP, in their naturally occuting conjugated form. Usual Dosage: See accompanying descriptive literature. Visit us at wunw PREMARIN.com @ NDC 0046-1102-81 PREMARIN\xc2\xae (conjugated estrogens tablets, USP) 100 Tablets Rx only 2 \xc2\xb0 N3 0046110281 8 & S 2 3 & Distibuted by MADE IN CANADA'
258e1602-a3cf-4ccc-ca80-73dbbfb812ff_133_7.jpg b'Dispenser Include \xe2\x80\x9cInformation forthe Patient\xe2\x80\x9d leaflet wth each prescription dispensed. Store at 20-25\xc2\xb0C (68-77\xc2\xb0F); excursions permitted to 16-30\xc2\xb0C (59-86\xc2\xb0F). [See USP Controlled Room Temperature] Dispense in tight (USP) child-resistant containers Each tablet contains 0.625 mg of conjugated estrogens, USP, in their naturally occuting conjugated form. Usual Dosage: See accompanying descriptive literature. Visit us at wunw PREMARIN.com @ NDC 0046-1102-81 PREMARIN\xc2\xae (conjugated estrogens tablets, USP) 100 Tablets Rx only 2 \xc2\xb0 N3 0046110281 8 & S 2 3 & Distibuted by MADE IN CANADA'
258e1602-a3cf-4ccc-ca80-73dbbfb812ff_133_8.jpg b"PREMARIN'0.625 mg [conjugted estrogens tabets, USP) istrcard oo s 0625 m aits \\ \\\\ u SPHATHIRR JIAM \xe2\x80\x98SEXNDBIEL] P 0 Y EWAPEN E I SIFAE 291 J0 DUEIEadde Y [2umesdwa) uiooy paij03u0) 45 Bs| 4.98-65) 2.06-51 0} P3RS SUASIONS 4. 1/ -89) DSTOT \xc2\xa5 310K U240 1PERI 30 1170 LOBD 3L |2 PUR 51 4334 WeISS3 BIY) KU ey ey 210N UiEID 1 P35 0pUa 335\xc2\xa7 U 1343 2up:afesod s \xe2\x80\x980L 210 ADUDSP ALY PUE\xe2\x80\x9cUIDIRIBP DIpOX] AU M 132 B2 RS b IV AL | \xe2\x80\x9cSap 23 o0 sEeUR Y ol wospab ok S apag | a5 afeuw papy ucadisaH (4571 \xe2\x80\x989310 SRBUS3P2NEDNAI) QU WES 410K 312y ok U \xe2\x80\x98UoneIpBIN J0 pUBIg ANOA ATU3PI 0} MOH . 450S1eto s et B 619 DSBS Ui TS S S ST R N"
258e1602-a3cf-4ccc-ca80-73dbbfb812ff_133_9.jpg b"v3s an3 Iv3SANIT & ZZZLT 215808 /| uBNaLS NS A LALTLS / 7 fu'xats 7, yesion Lo NDC 0046-1102-51 V3S N4 Iv3Isan3d Tv3s N3 \xe2\x80\x98"
2bced627-51e3-4e5c-a23c-30deb86ff37b_500_10.jpg b'swige aseoja-gapuapy (suipejuEWwE) Y3.xe|owsQ JVSIH HOd LON TS SR y1-910-52089 OON 14Tl 2047 4Tl 2067 NDC 68025-076-14 Uk Dose Bastor Packs. | NDC 68025-076-14 ot tos bt Fke. SAMPLE Osmolex\xe2\x80\x9d"ER NOT FOR RESALE (amantadine) Extended-release Tablots f \'Osmolex\xe2\x84\xa2ER (193ma] (amantadine) Extended-relgase Tablsts Eh et cntos 146 g cncrtagn {eqent 0 240 mg et oo USP, i Dosage: oo posrbing nosion Soro 26 25\xc2\xb0 TR excusare ol 0 15690 (0 ) 1550 USP Conoied FcmTorpae, T s kg s ol st KEEPOUT OF REACEHOF CHLDREL, sige sseqa- el (SUIPEIUBLUE) 1y 5y XD|OWUSO P01200 Nutra Med Osmolex 193 mg 14ct Prog# 0768187C 04/03/18 SeIEL oseole-popuard Black Pantone Pantone ~ (suipejuBWE) oz 3 . Xs|owsQ 3vS3d Ho4 LON FdWYS Osmolex\xe2\x84\xa2ER (amantadine) exendsd.eiase asets Sfoed Jeysig 850 Hun (1x1) 2 \'swigeL v}'
2bced627-51e3-4e5c-a23c-30deb86ff37b_500_6.jpg b'Each tablet contains 258 mg \xe2\x80\x98amantadine (equivalent to 320 mg NDC 68025-077-90 amantadine hycrochiorde USP). SEE PACKAGE INSERT FOR \xe2\x84\xa2 @ DOSAGE INFORMATION, s m o ex S Swallow whole: S Do not spit crush, or chew. . S Keep out of reach of children. (amantad"]e) o Store at 20\xc2\xb0C-25\xc2\xb0C (68\xc2\xb0F-77\xc2\xb0F); S excursions permitted to 15\xc2\xb0C-30\xc2\xb0C Extended-release Tablets 2 (59\xc2\xb0F-86\xc2\xb0F) [See USP Controlled S Room Temperature]. 8 S = RTICAL = ek ie 5 Distrbuted by: Vertical Pharmaceuticals, LLC Bridgewater, NJ 08807 90 Tablets Rx Only 200131 Rev. 03/2018'
2bced627-51e3-4e5c-a23c-30deb86ff37b_500_7.jpg b'707 Tabets Un oss BistrPck NOG 68025-075-07 LOT X00000\xc2\xa2 EXPX0000K: SAMPLE | NOTFOR RESALE Osmolex"ER (amantadine) Exndet s Bt Rx Only Each tablet contains 129 mg amantocine. (oquivalnt 1o 160mg amantadine hydrochioride USP). V&mw e 707 Tabkts U Dose Bister Pack DG 68025-075-07 LOT XXX EXPXXP00X. \xe2\x80\x9cSAMPLE NOT FOR RESALE Osmolex\xe2\x80\x9dER (amantadine) e s Tots Rx Only _ Each tablet contairs 129 mg amantadine (equivalent 10 160 mg \xe2\x80\x98amantadine hydrochloride USP). 200222 Fow.03/2018 7907 Tabkets Ui Do Bt Pack NOC 58025-075-07 LOTX0000X EXP XX00K SAMPLE NOT FOR RESALE Osmolex"ER (amantadine) Exodes s ol Rx Only Each tabletconteifs 129 mg amantadine (oquivalent 10160 g amantadine hydrochiorkde USP). VERTIGAL 200222 Row 03/2018 7147 Tathets Ut Dose Blster Pack NOC 68025-075-07 LOT XX000X EXR XXX SAMPLE NOT FOR RESALE Osmolex\xe2\x80\x9d"ER (amantadine) /| s oss s Rx Only. Each tablet contains 120 my \xe2\x80\x98amantacine equisent t0 160 g \xe2\x80\x98amantadine hydrochloride USP). Vuncu B'
2bced627-51e3-4e5c-a23c-30deb86ff37b_500_8.jpg b'swige aseojargapuapy (euipejuEWwE) Y3.xe|owsQ JVSIH HOd LON TS SR 161052089 OON 14Tl 27 4Tl 2067 NDC 68025-075-14 Uk Dose Bastor Packs. \xc2\xa9 NDC 68025-075-14 U Dose Bister Packs. SAMPLE - Osmolex"ER HOT FOR RESALE (amantadine) Extended-release Tablots - f \'Osmolex\xe2\x80\x9dER Hom (amantadine) Extendsd-rolase Tablets Eh et o 129 mgcncetad: {eqent 0160 mg et oo USP, 120 mg i Dosage: oo posrbing nosion Soro 26 25\xc2\xb0 TR excusare ol 0 15690 (0 ) 1550 USP Conoied FcmTorpae, T s kg s ol st KEEPOUT OF REACEHOF CHLDREL, w21 . 21 Detruted by Vil Pamacsics LG B, 10 0207 ot siaeL sseqa-puaid (SUIPBIUBLUE) 1y 5y XD|OWUSO ! \xe2\x80\x94 ) P01201 Nutra Med Osmolex 129 mg 14ct Progi# 0768187C 04/03/18 Bw 621 Sjo|qe aseafal-papuard Black Pantone Pantone (suipejuBWE) oo 3 . Xs|owsQ 3vS3d Ho4 LON FdWYS Osmolex\xe2\x84\xa2ER (amantadine) exendsd.eiase asets Sfoed Jeysig 850 Hun (1x1) 2 \'swigeL v}'
2bced627-51e3-4e5c-a23c-30deb86ff37b_500_9.jpg b'7 {1x7)Tabets UniDose Biser Pack DG 68025.076.07 LOT Y0000 EXPX0KX0X- SAMPLE NOTFOR RESALE Osmolex\xe2\x80\x9d"ER (amantadine) . et s i Rx Only Each tablet contains 183 mg amantaine (equivalent 10 240 mg amantadine hydrochlonide USP). VERTICAL 200223 BrSeome 710 aets Uit Dose BstrPack DG 68025.076.07. LOT XH0000KX EXP X000 SAMPLE NOT FOR RESALE (amantadine) e Tvts Rx Only. Each tablet cortains 193 mg amanadine (equivalent 10 240mg. \xe2\x80\x98amantadine hydrochloride USP). VETcAL 200223 Rev.03/20%8 7 (97 Tabkts Uit Dose Bister Pack DG 6025-076.07 LOT 00000 EXP. XOX/X00K \xe2\x80\x9cSAMPLE NOT FOR RESALE Osmolex"ER (amantadine) Extnces s s RxOnly Each tablet contars 193 mg, amantadine (oquivalont 10240 mg \xe2\x80\x98amantadine hydrochioride USP). 20023 Row 0372018 7 (17 Tathets Ut Dose Blste Pack NDC 68025.076-07 LOT X00000X EXP XXX - \xe2\x80\x98SAMPLE NOT FOR RESALE Osmolex\xe2\x80\x9d"ER (amantadine) Exondes s it Rx Only Each tablet contaips 193 mg. \xe2\x80\x98amantacine foquialent 10240 mg \xe2\x80\x98amantadine hydrochioride USP).'
2d77412a-e084-4406-ac33-d882aece9354_308_6.jpg b"\xe2\x80\x9cEach film coated tablet contains: NDC 16729-1 50_1 0 Quetiapine Fumarate, USP equivalent to N Quetiapine 400 mg . = USUAL DOSAGE: See accompanying Quetlaplne 3 SRTe resT50To TN Prescribing Information. S WARNING: As with all medications, Tahlels, USP = keep out of the reach of children. - Store at 25\xc2\xb0C (77\xc2\xb0F); excursions = X permitted to 15 to 30\xc2\xb0C (59 to 86\xc2\xb0F) [see USP]. 400 'l > ov';fce(fd?rr\xe2\x80\x98zagta;':\xe2\x80\x98f\xe2\x80\x98&;'zsgaf::emf:\xe2\x80\x98rrix Medication guide available at 0 45X 22 mm www.accordhealthcare.us/products Rx Only ~ Manufactured for: Attention Pharmacist: Dispense the o Accord Healthcare, Inc., enclosed Medication Guide to each & Durham, NC 27703. patient. ,c_\xe2\x80\x99 Manufactured by: e Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213. INDIA 30 Tablets Mfg. Lic. No.: G/25/1883 o rd Il"
2f7d5e7f-79aa-4f3a-b9a6-758d9f3ce74d_589_6.jpg b"NDC_49884-05(_5-10 Imipramine Hydrochloride Tablets, USP 50 mg PHARMACIST: PLEASE DISPENSE 'WITH MEDICATION GUIDE Rx only 1000 Tablets IPAR Each tablet contains: Imipramine HCI, USP 50 mg USUAL DOSAGE: Read Accompanying Literature KEEP THIS AND ALL DRUGS OUT OF REACH OF CHILDREN. Dispense in a tight, light-resistant container as defined in the USP. Store between 15 to 25\xc2\xb0C {59\xc2\xb0 to 77\xc2\xb0F). LAOB6-10-1-13 RO1/16 Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 3 49884-056-100"
3275b824-3f82-4151-2ab2-0036a9ba0acc_130_10.jpg b'DOSAGE AND USE: See accompanying prescribing Informaon Store at room temperature, 2\xc2\xb0C1025\xc2\xb0C (8\xc2\xb0Fto T7\xc2\xb0F). [See USP Controlled Room Temperature.] Dispense In tight (USP), ight-resistant (USP), and child-resistant containers. Distrbuted by Wyeth Pharmaceuticals Inc Asubsidiary of Pizer Inc Philadelphia, PA 19101 MADE IN JAPAN FPO UPC 80% x 5.5 mm 0008-1042-05 1 ALWAYS DISPENSE WITH MEDICATION GUIDE NDC 0008-1042-05 Rapamune\xc2\xae (sirolimus) Tablets For oral use only. 100 Tablets Rx only GTIN: 00300081042051 LOT:/EXP: PAAD63671'
3275b824-3f82-4151-2ab2-0036a9ba0acc_130_6.jpg b'Lotorois000Emn 1 ALWAYS DISPENSE WITH MEDICATION GUIDE @ oo | Rapamune\xc2\xae | Rapamune\xc2\xae (sirolimus) Tablets | (sirolimus) Tablets For oral use only. Unit Dose - 100 Tablete Unit Dose - 100 Tablets (10 Bister Gards of 10 Talets Each) Rxonly | (10 Biser Cards of 10 Tablets Each) (w3 oL om0 e 01) o 004 - meq i sje|qe] (snwijoais) Lunwedey @ DOSAGE D USE: See aompamyig presnbng nfomaton. i oS T e e @ e s Tt die pckageis ot il st 1 ispansd foroutatert use, a chi-resisrt ortiner bttt i Rapamune\xc2\xae sttty (sirolimus) Tablets Wyeth ramacoutcas e Aubsitiny d Pizeroc iladepi,PA 16101 MADE W Pl . \xe2\x80\x9dI\xe2\x80\x9c \xe2\x80\x98\xe2\x80\x9d ||\xe2\x80\x98|Iu|\xe2\x80\x99 Unit Doss - 100 Tablets $70008-1040-10 1 (10 Blister Cards of 10 Tablets Each) PRADOGRO0'
3275b824-3f82-4151-2ab2-0036a9ba0acc_130_7.jpg b'DOSAGE AND USE: See accompanying prescribing nformaon Store at room temperature, 2\xc2\xb0C1025\xc2\xb0C (8\xc2\xb0FtoT7\xc2\xb0F). [See USP Controlled Room Temperature.] Dispense In ight (USP), ight-resistant (USP), and child-resistant containers. Distrbuted by Wyeth Pharmaceuticals Inc Asubsidiary of Pizer Inc Philadelphia, PA 19101 MADE IN JAPAN \xc2\xa3 \xc2\xa3 \xc2\xa9 I = s 8 \xc2\xa9 2 5 o a o ALWAYS DISPENSE WITH MEDICATION GUIDE @ NDC 0008-1041-05 Rapamune\xc2\xae (sirolimus) Tablets For oral use only. 100 Tablets Rx only < o = 3 o S S S = o S = e o a > - S S PAAD63670'
3275b824-3f82-4151-2ab2-0036a9ba0acc_130_8.jpg b'ekm. B 1oiGeL (snwiors) eoUhwedey 01-1\xc2\xa504-8000 0N 180980Wd 10161 Vd \xe2\x80\x98Blilud 1024410 ang \\ wekm. Bw | 19yeL (Snuwijolts) sunwedey 701-8000 OON = 180980Wd L0161 Vd \xe2\x80\x98Bllud 5 = > \xe2\x80\x9cujiezyd jo ng ekm. 21 (snwijons) sounwedey 01-1\xc2\xa504-8000 OAN g 180980Wd 2 2\\ 10161 vd Bl 1402l 10 qnS eAm . Bw | 1. (snwions) < 180980Wd 5\\_\\;{);5;\\@ \xe2\x80\x9celd 1162y Jo an\xc2\xa7 wekm. b w | 1. (snwors) 4 i \xe2\x84\xa2\\ 180980Wd | NDC 0008-104 < 2 3\\10161 vd \xe2\x80\x98Blud 1167 J0 an\xc2\xa7 Rapamune\xc2\xae (s\\mhmus\xe2\x80\x9d t Wyath Sub of Pfizer In Phila, PA19101 3% ; PAA0B6081 = NDC 0008-1041-10 Rapamune (sirolimus) Tablet Wyeth Sub of Pfizer | Phila, PA19101 N2 2 PAAOBE0BT g NDC 0008-1041- 10 Rapam (s\\mhmus}T e( Wyelh Sub of Pfizer | Phila, PA 19101 PAAOBG0BT = = x NDC 0008-1041-10. Rapamune\xc2\xae & (sirolimus) Tablet 1 m Wyeth 9 Sub of Pfizer | Phila, PA19101 N2 2 PAA0BG0BT g NDC 0008-1041-10. Rapamune\xc2\xae = (sirolimus) Tablet 105 Wyeth Sub of Pfizer | Phila, PA 1910135 PAA0BG0BT = > = g S 5==c'
3275b824-3f82-4151-2ab2-0036a9ba0acc_130_9.jpg b'ALWAYS DISPENSE WITH MEDICATION GUIDE @ NDC 0008-1041-10 @ Rapamune\xc2\xae | Rapamune\xc2\xae (sirolimus) Tablets | (sirolimus) Tablets For oral use only. Unit Dose - 100 Tablete Unit Dose - 100 Tablets (10 Bister Gards of 10 Talets Each) Rxonly | (10 Biser Cards of 10 Tablets Each) \\ / o =] M/ A e (oL 0 o) s 01) v 004 - weq s19|qeL (snwijous) gaumuedg_-: /\xef\xac\x81\\ DOSAGE D USE: See azompamying pesrbig nfmaton. Stre roam temperatre, 207 1025\xc2\xb0 69 o TFF). @ 5 USP Cnloled oom Temperature] Prolct bom ight it doe pckageis ot chil st i e Rapamune\xc2\xae ety (sirolimus) Tablets o i o Aubsitiny d Pizeroc ildepia,PA 19101 ADE I P " \xe2\x80\x9dl |\xe2\x80\x9d |||I Unit Dose - 100 Tablets $70008-1041-10 5 (10 Blster Cards of 10Tablets Each) o | -'
35c7aa71-6171-4ba5-916c-384c28e5f5c1_516_6.jpg b'L L NDC 70954-021-20 oo opene optlsprosi ol U5 PI\xe2\x80\x99aZOSin m\\"gz\xef\xac\x81;\xef\xac\x81mmmwu package insert for complete - H d hl .d ?mmm\xc3\xa9\xef\xac\x82\xe2\x80\x9c;n?\xef\xac\x81\xe2\x80\x9c\xef\xac\x81 (68\xc2\xb0 10 77\xc2\xb0F). [See USP Controlled Room o (% emporabre = ydrochloride T vesmion =" = Capsules, USP pemsenassuimimsimomnsosnaione == \xc2\xa7 % e conainer bty cose i < m This package s hi-sstnt. =3 = Keep this and all medications out of the reach of children. g Rx only Mot rarsa 16 v o 70 Lake Drive, East Windsor zm Z G New Jorsoy 08520 TOVILUM 250 Capsules v 0018 Wnison'
3653a602-4551-4e6c-84a7-31861f5dc482_609_6.jpg b'QI iFA) RO ) 450 Logealy ajeunidfy auosajsojsa 07-910-95L29 ION PJSBOS1AC Each mL contains testosterone. cypionate, USP 200 mg. Also contains berzyl benzoate, 0.2 L benzyl alcohol added s presenvative, 945 mg; n cotonseed of, 560 mg. USUAL DOSAGE: S\xc3\xa9e accompanying prescibing informaton. Warming and shaking the val should edissove any crystal that may have formed during storage a temperatures lower than recommended. Store a1 20\xc2\xb0t0 25\xc2\xb0 (6810 T7\xc2\xb0). {See USP Contrlled Room Temperatire]. Store product in this carton to protect contents from lght. Distibuted by: Sun Phammaceutical Indusiries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat India. NDC 62756-016-40 Testosterone Cypionate Inecton, USP~ (05 2,000 mg/10 mL (200 mg/mL) FOR INTRAMUSCULAR USE ONLY 3 | I 627561101640 GUJDRUGS28395 PUSBOBIAC 1SS 11/2016 NDC 62756-016-40 Testosterone Cypionate Ineeton, USP (5 (200 mg/mL) FOR INTRAMUSCULAR USE ONLY Rx only L 10 mL | 9 \\ Muttiple-Dose Vial \xef\xac\x81k}x NDC 62756-016-40 Testosterone Cypionate Injection, USP G 2,000 mg/10 mL (200 mg/mL)'
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_10.jpg b'20 mL Single-dose Rxonly NDC 0409-4776-10 Preservative-Free FOR INFILTRATION AND NERVE BLOCK INCLUDING EPIDURAL AND CAUDAL. Each mL contains idocaine hydrochloride Lidocaine B \xe2\x80\x98mg; sodium chloride 6.5 mg. May contaln sodium hydroxide and/or 1 0 | (o TSIV 1 crochiorc aci for pH adjustment. p W /0 6.5 (5.0 t0 7.0). Sterlle, nonpyrogenic. ELLLLETRUR TN (o osage: See insert. Store at 20 to (15 mg/mL) 25\xc2\xb0C (68 to 77\xc2\xb0F). [See USP Controlled Room Temperature] Hospira, Inc, Lake Forest, IL 60045 USA RL-4791 Hospira'
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_16.jpg b'10 mL Single-dose NDC 0409-4282-12 Preservauve Free Rx only Each mL contains lidocaine HCl, [0 (Y- 1170 s (@ W 2nhyd. 20 mg; NaCi6 mo. May contain HCl and/or NaOF for pH 200 V[ fo T PN I ciusten. i 65 5010 7.0 Sterile, nonpyrogenic. Usual pL LR T TR LN I ciosage: See insert. Discard unused portion. Store at 20 to 25\xc2\xb0C (68 to (20 mg/mL) 77\xc2\xb0F). [See USP Controlled FOR INFILTRATION AND NERVE BLOCK "o0\xe2\x84\xa2 Temperature] INCLUDING EPIDURAL AND CAUDAL. RL-4797 Hospira Hospira, Inc, Lake Forest, IL 60045 USA "l Il ||I "II| "I | \xe2\x80\x9dII Il'
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_17.jpg b'e EPIDURAL AND CAUDAL. Hospira | EPIDURAL AND CAUDAL. | 10mL 25 Single-dose Ampuls. NDC 0409-4282-02 | 10 mL 25 Single-dose Ampuls. NDC 0409-4282-02 | Preservative-Free X | preservative-Free Bronh) | | 3 Lidocaine HCl \xc2\xa7 ALY T (o] | Injection, USP ! Injection, USP | 200 mg/10 mL i 200 mg/10 mL | (20 mg/mL) | (20 mg/mL) i FOR INFILTRATION AND NERVE BLOCKS INCLUDING % i FORINFILTRATION AND NERVE BLOCKS INCLUDING | | | | | | | VAN aNY 1VNaIda ONIGNTINI SHD018 IAYIN ANV NOILVHLTIANI HO4 (Jw/bw 07) RN T4 dsn \xe2\x80\x98uondafuj PTEIUCELTTY 2214-3An0MI3591d fuo xy 202824600 YN sinduwy 3sop-2(Buis 5z W Q| j i 10 mL 25 Single-dose Ampuls NDC 0409-4282-02 | Each mL contains lidocaine hydrochloride, anhydrous 20 mg;sodium ! Rxonly | chloride 6 mg. May contain hydrochloric acid andor sodium hydroxide for pH adjustment. pH 6.5 (5.0 to 7.0). Serile, nonpyrogenic. Usual dosage: Seeinsert. Discard unused portion. Store at 20 t0 25\xc2\xb0C (68 to 77\xc2\xb0F). [See USP Controlled Room Temperature] Preservative-Free Lidocaine HCI 2% Injection, USP 200 mg/10 mL (20 mg/mL) RINFILTRATION AND NERVE BLOCKS INCLUDING EPIDURAL AND CAUDAL. 3 Hospira, Inc, Lake Forest, IL 60045 USA'
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_18.jpg b"Reony NDC 0409-4277-16 20 ml T FORINFILTRATION AND NERVEBLOCK. [RLLT ] TN Lol | 2% Injection, USP 20 mg;sodm cride 6 mg; mefpataben't o adoed a5 presentive. May contain HCl andior NaOH for pH b oS a0 e oo tog e 400 mglzo L \xe2\x80\x98dosage: See insert. Store at 20 to 25\xc2\xb0C (68 to 77\xc2\xb0F). [See USP (20 mg/mL) Cantrolled Room Temperature] Hospira, Inc, Lake Forest,IL 60045 USA RL-4678"
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_19.jpg b'[20 ML 25 Multiple-dose Fiiptop Vials Reonly NDC 0409-4277-01 FORINFILTRATION AND NERVEBLOCK. Lidocaine HCI S PRI g oL (20 mg/ml) Hospr Store 2 20 10 25\xc2\xb0C (68 077\xc2\xb0F). [see USP Controlled foom| Temperature.] oy poIpA et Aeangenasaid OLLpOpAY: VSN 570091 353103 afE7 Ul Bk ue 3p huga <3 g2 52 pabeuwiepun pue 11 Ajuo 350 vasu aas rabesop ey [USE ASEPTIC TECHNIQUE aspi Remove cover from phastic vialand cleanse stopperwith | eudson LTV R o LRl ] A)z 5 P amiumope e o | [JH 2U1EI0PI] loutmodm won omm gt seadents =opaRmMN S T 07|'
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_20.jpg b'5 Reonly NDC 0409-4276-16 PR Multiple-dose FOR INFILTRATION AND NERVE BLOCK. e e ) Lidocaine HC| | MGG jecti et el njection, USP | se s onetvite st i 65 (50 0 20, Sene onpyrgenc. sl dome: e 200mg/20 mL | s wanto s otor7F) < [See USP Controlled Room Temperature ] (0mg/ml) | rees camin aLaczs. Hodnka'
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_6.jpg b'30 mL Single-dose Rx only NDC 0409-4279-16 ive-| FOR INFILTRATION AND NERVE BLOCK Preservative:hree INCLUDING EPIDURAL AND CAUDAL. id . || e comans ascane v, s Lidocaine HC 10 mg; NaCl 7 mg. May confaln HCl R andfor NaOH for pH adjustment. pH 65 = Injection, USP (50 to 7.0). Sterlle, nonpyrogenic. Usual = dosage: See Insert. Discard unused portion, Store at 20 to 25\xc2\xb0C (68 to 77\xc2\xb0F). 300 mg/30 mL [See USP Controlled Room (0mg/ml) | e Hospira, Inc, Lake Forest, IL 60045 USA RL-4789 Hospira'
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_7.jpg b'i and seal & [sch L contains idbcaie hydrochbrde, anfydous 10 g, Usual dsge: See nsert Use oy 1 act o s 7 mg. Ve Crtan ydracione 3\xc2\xa2 ander and.undamases. Coans o bacteosat e prompe o e st H 65 5,01 7.0, Gsordunisatporion E\xe2\x80\x94 s, Lok s L6003 U5 38 \xc2\xa3 &y scl3d 5 wegl|e & : =8328| & ; $3g2 i e w3 g Bl 58 g0 3% \xc2\xa3 - 2 323 g i 8 gfd \xc2\xa385 252 885 EEH B ) .- 5 gsf 3 B g 3 g g 2 25 2> g2 = .= \xc2\xa7 EH U E amng . = SF 3 |3 RE ile 25 s |EZ 2E \xc2\xa7 |\xc2\xaeB2Es i lgss2 : | 8g {g|BER 45\\ 0= it o B EJ 2 & vaudpomin e famyenduny bda ooy P10 s 991 (4L 01 ) 152 0107 0 9IS By Ao pue SRILG Jo [eAcu oy KiSo30 wouad psnun s \xc2\xa2 o og womnes pssonanwis o1 bt \xc2\xa2 P nepn 2 saddo1s pue Jeasiano \xe2\x80\x98qe) anoway | pdagiue yum saddorsasu &) qel iy 1 Aprewsayy INDINHIL IUIISYISN|'
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_8.jpg b'One/No. 0409-4270-11 Lidocaine HCI Injection, USP 300 mg/30 mL (10 mg/mL) 30 mL sineLe-pos viaL'
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_9.jpg b'733, o Sterile Pack One/No. 0409-4270-11 Preservative-Free Rxonly Lidocaine HCI Injection, USP 300 mg/30 mL (10 mg/mL) 30 ML SINGLE-DOSE TEARTOP VIAL FOR INFILTRATION AND NERVE BLOCK INCLUDING EPIDURAL AND CAUDAL. Each mL contains lidocaine hydrochloride, anhydrous 10 m; sodium chloride 7 mg. May contain hydrochloric acid and/or sodium hydroxide for pH adjustment. pH 6.5 (5.0 to 7.0). Store at 20 to 25\xc2\xb0C (68 to 77\xc2\xb0F). [See USP Controlled Room Temperature.] Contents sterile inintact unit package. Medication sterile and nonpyrogenic. Usal dosage: See insert, Discard unused portion. TY-0375 Hospira, Inc., Lake Forest, IL 60045 USA Hospira'
47924917-bbd5-45de-96cb-c7ff9754da97_236_6.jpg b'am splqeL wnp(e) unelseAnsoy (Dot ines nct o e prinied) UNVARNISH ZONE \xe2\x80\x9cOver printing Zone 203 (3o fmama OANIOH &) sia|qeL wnia|eg ujjejseAnsoy Ao xy A-GHZ-2989 AN \xe2\x80\x9cEach il <gatd ablet cotain: Rsuvastat ki equivalint o osiastain 20mg sl Dasag: oa accompanying Prscibin infomation. WARNING: A witha mcicaions, ksp ot of thrach of i, This untdoss package s ehilresistan. S a2 075 779 s || pamited o 151030 (30 0 85%) NDC 65862-295-06 {5 USP Controld oo Temparatr] Protctfrom malstre. Rxonly Rosuvastatin Calcium Tablets /8D AUROBINDO 60 (10 bistercads sachcotasing ables) Tablets Disbutsdby: Rosuvastatin Calcium Tablets am [ \xe2\x80\x94\xe2\x80\x94\xe2\x80\x94\xe2\x80\x94\xe2\x80\x94 Auobindo Phama USA, nc. 270 Prnctonigisiown Rosd East Windsor, W 08520 Matainngia Cotl: TSDRUGS 191003'
47924917-bbd5-45de-96cb-c7ff9754da97_236_7.jpg b'*Each film-coated tablet contains: Distributed by: NDC 65862-296-30 Rosuvastatin calcium equivalent to Aurobindo Pharma USA, Inc. rosuvastatin 40 mg 279 Princeton-Hightstown Road East Windsor, NJ 08520 Usual Dosage: See accompanying Rx only Prescibing Information Made in Indiz 5 < Code: TS/DRUGS/191993 WARNING: As with all medications, Rosuvastatin Calcium keep out ofthe reach of children. - P1421614 5 Tablets Store at 20\xc2\xb0t0 25\xc2\xb0 (68\xc2\xb0 1o 77\xc2\xb0F); m excursions permited to 15\xc2\xb010 30\xc2\xb0C (59\xc2\xb0to B6\xc2\xb0F)[see USP Gontrolled Room Temperature]. Protect from /2 AUROBINDO 30 Tablets moisture. *Over Printing Zone Coding Area (#5x15mm) Doted ines not o be printed'
47924917-bbd5-45de-96cb-c7ff9754da97_236_8.jpg b'(oed ins no o be priec) UNVARNISH ZONE \xe2\x80\x9cOver printing Zone \xc2\xa5 \xe2\x80\x98S91qeL (s1]qe 0} bupureina yoea spiea saisiig 0F) 00} oaNigouNy \xc2\xa2 S]9]qe] WNI9[B] URISEANSOY 01-96Z-2989 9aN Ao \xe2\x80\x9cEach film-coated tablet contains: Rosuvastatin calcium equivalentto rosuvastatin 40 mo. Usual Dasage: See accompanying Prescribing Information. WARNING: A5 with all medications, keep ot of the reach of children \xe2\x80\x9cThis unit-dose package is child-resistant. Store at 20\xc2\xb0 to 25\xc2\xb0C (68\xc2\xb0 to 77\xc2\xb0F): excursions permitted fo 15\xc2\xb0 to 30\xc2\xb0C (59\xc2\xb0to 86\xc2\xb0F) [see USP Gontrolled Room Temperature]. Protect from moisture. Rx only NDC 65862-296-10 Rosuvastatin Calcium Tablets /D AUROBINDO 100 (10 blister cards each containing 10 tablets) Tablets Rosuvastatin Calcium Rirobindo Pratm USA, i 279 Princeton-Hightstown Road Tablets East Windsor, NJ 08520 e s 100 (10 bister cards eachcontining 10 tablets) Tablets Code: TSIDRUGS/19/1993'
49289133-6071-406e-8b18-73a6e4db8782_48_6.jpg b'femprare] Dextroamphetamin S i = oamph o (] e seed Saccharate, Amphetamine gt s, 5P (253 f il Aspartate, Dextroamphetamming sy o moogsmcctin Sulfate and Amphetamine Tousios Dipense i g gt et ctier as Sulfate Tablets definedinthe SPucing achilf-rsistn chure, Yo gty e (Mixed Salts of a Singie " - m Entity Amphetamino Product) Kt s andalmedcsion ol PHARMACIST: Dispense the accompanying Phormaceutcs . g Medication Guide o cach paient. M B U5 z Ve |'
49289133-6071-406e-8b18-73a6e4db8782_48_7.jpg b'storeat20\xc2\xb01025\xc2\xb0 601077, [ R G YA Each it onians 75 o f See USP Contolec Room et ot 1oyl Lt + | s ntaniv: s cqiet 75 Tamaeinl \xe2\x82\xac anphetarie st oncha, 1 5m3 of deanphanine e, SPond 5 gt gt U5 (83t v et b i) [ \xe2\x80\x94\xe2\x80\x94\xe2\x80\x94\xe2\x80\x94 et pense it it st ot o delne nih ISPusing it chure Mixed Satsofa Single Kospcorter ity ced. " Entity Amphetamine Product) Kees s adall medcaton out of PHARMACIST, ispense the accompanyind| s mscsiss . Medication Quide o sach patient. Mo 5% A 4 L) PRy Mylane | win com RM4547A'
4be76756-4114-4d50-a36c-fd410f6c773d_911_10.jpg b"12L9505L 9 \xc2\xa36m6lSymBiE0 \xc2\xa3 OO 10T ARAXIOVIOT IO AR A G8/0ANSZISOHT/HN \xe2\x80\x9cN ) \xe2\x80\x9cpascto ApuBy Jeuuco deay ainsofn Wesisepyp \xc2\xa9 Busn .zz;gsu uRlsEUB 40 U suedsig 2 -8 s o 23 e EC) R \xc2\xa9.2 @ 25| =0 g \xc2\xbb'\xc2\xa9 =2 (RS P B HE =T [=12 S5G N2 FlT o= )22 SEg E[EH - i ES]EEH B << <0~ bl 52 *Each fim-coated taletcontains amicdipine besyiate, USP equivalentto amlodipine and atorvst calsium, USP equivalentto 40 mg of atonastatin Usual Dosage: See ascampanying Keop i and the reach of children. Store at20\xc2\xb0 10 25\xc2\xb0C (68\xc2\xb0to 77\xc2\xb0F). [See USP Controlled Room Temperature] Manufactured fo Hylan Pharmaceuticals Inc. Morgantown, WY 26505 U SA ade in india [Mylan\xc2\xae |wyiancon RMX4519H1 |"
4be76756-4114-4d50-a36c-fd410f6c773d_911_6.jpg b'P1\xc2\xa39505L \xc2\xa36-516y-8450 & OO 10T 5RXIUEIOT \\__z_g_sj Tablets npc 0378-4515.03 Amlodipine Besylate and Atorvastatin Calcium [ PHARMACIST: Dispense the accompanying Patient Information Leaflet to each patient. Myian Pharmaceuticals Inc. Mosgantown, WY 26505 S A Mate ininda [MMylan\xc2\xae | . R === U RMXAS15H1'
4be76756-4114-4d50-a36c-fd410f6c773d_911_7.jpg b'[ e, ST i = of il s o, 4 ini bty o 50 o of st Amlodipine Besylate and 78=4516=93 5 = Lo 4 il il = et Atorvastatin Calcium gy st s croner B Keep tis and all medicatimnoutor e Tablets a5 dfid e USP using a chiresstant 5 \xe2\x80\x94\xe2\x80\x94 e o = Store ot 20\xc2\xb0 1 25\xc2\xb0C (68\xc2\xb0 1o 77, fSee Keep cotanr ity . = USP Controled Room Temperature.] 5 mg/80 mg Gode No: MH/DRUGS/25/NKD/BS Manufactured for PHARWACIST: Dispense the accompanyi Mylan Pharmaceuticals nc. Patient Information Leaflet to each pat Morgantown, WV 26505 U.S.A. = @ Mylan\xc2\xae \xe2\x80\x98GTIN TXXTOTRY y! % SN TooooToO [MMylan | o S LOT X000 o RS 16H1'
4be76756-4114-4d50-a36c-fd410f6c773d_911_8.jpg b'LVL9505L 7 \xc2\xa36milSymBIS0 \xc2\xa3 IO 10T ARAXIONIOT O S IO NI BH/DINSSINHA \xe2\x80\x9cN ) \xe2\x80\x9cpasofa Ky seupauos doay z 3 2 & C\\EEH o E 55 .2 |58 =2 82 g2 83 25 qo - Ballss ~EESEN E e = s [=4)22 4.m.\xe2\x80\x9d51 .m 45 55 25| i < ol 2 SJEEECIO | \xc2\xa2 << <T - b |EE *Each filn-coated tablet contains amlodipine besyiate, USP equivalentto 10 mg of ambdpine and atorvast calsium, USP equivalent o 10 mg the reach of Store at 20\xc2\xb0 [5ee USP Controlled Room Temperature] Manufactured for Mylan Pharmaceuticals Inc. Morgantown, WY 26505 U SA Made it nda [MMylan\xc2\xae |wyn.con i RMXA517H1'
4be76756-4114-4d50-a36c-fd410f6c773d_911_9.jpg b'6149505L 6 \xc2\xa36m3icyegic0 \xe2\x82\xac OO 10T ARAXIOVIOT OO S IO TS BHOINS/SOMHIHA: ON 200 \xe2\x80\x98eSO B euieuco daay ainsop wasisei-pyup @ T pense the accompan) Leaflt to each pa inc 0378-4518.-03 Tablets ) o 5 & *Each fim-coated abletcentains anlodipine besylate, USP equialent , USP equivalent to 20 mg of aterastatin [5ee USP Gontralled Room Temperature] ,fgz_v._m.._s i'
4c5c2d3f-5038-41a1-a2fe-4dcd048dbac1_187_6.jpg b'NDC 0336.500-41 Code 263505 o o msomt Code 263505 RNOT \xe2\x80\x98GALAXY contrr \xe2\x80\x98e Mangygen: AT, L5 a0 1 AL Ty Y s e e AU W S e et s g 0155 g S e ol vt 1Ly 51 B, At b s et Ot Sty el Sk T s O QUm0 P e . 1 e e s, HERTI Bty 2 e, D oo R St 7 GALAXYcanar s orpregn: o U5 e 1 S Tyt s e e AU W S e Wi s 1055, g G e . ol vt 1) S5 sy, At s et Ot eyt B AU e iy e 2 i 5 s, e e e ol et 9'
5017a927-2a24-4f27-89f9-27c805bf7d59_401_6.jpg b'E06LES<IVIN> (1wL/Bwoor) gl ooy wgrug0g ,x"\xef\xac\x81\xef\xac\x81annv 2600290500500 NILO_| Lovenox\xc2\xae (enoxaparin sodium injection) B ONLY Each 0.1mL of LOVENOX\xc2\xae Injection contains 10mg enoxaparin sodium derived from porcine intestinal mucosa in Water for Injection and 1.5mg benzyl alcohol. Dosage and Administr: r subcutaneous or jection. See package dosage information and directions for use. WARNING: Keep out of reach of children. Store at 25\xc2\xb0C (77\xc2\xb0F); excursions permitted to 15-30\xc2\xb0C (59-86\xc2\xb0F) see USP Controlled Room Tempera- ture]. Do not store the multiple dose vials for more than 28 days after the first use. sanofi-aventis U.S. LLC NDC 0075-0626-03 Bridgewater, NJ 08807 ASANOFI COMPANY \xc2\xa92013 - 50124924 300me3m (100mg/1mL) R ONLY For Subcutaneous or Intravenous Injection Maultiple Dose Vial One 3ml Vial SANOFI NDC 0075-0626-03 LOVENOX\xc2\xae (enoxqpani Sodum injection) 300053 (100mg/imt) RONLY For Subcutaneous or Intravenous Injection Multiple Dose Vial One 3mL Vial <MAT>537903'
5017a927-2a24-4f27-89f9-27c805bf7d59_401_7.jpg b'| Lovenox\xc2\xae (enoxaparin sodium injection) | Rowny fach LOVENOX\xc2\xae Syringe ~ contains | 120mg enoxaparin sodium injection derived from porcine infestinal mucosa L inWaterfor Inecton. Dosage and Administration: For sub- | cutaneous injection. Se package insert for dosage information and directons ~ /LOVENOX | e \\ (enoxaparin sodlum injection) | ARG, o ut of reach of e e | Store_at 25\xc2\xb0C (77\xc2\xb0F;_excursions 120:50.8n | St -t Soacmins | RONLY | SINGLE DOSE SYRINGES WITH AUTOMATIC SAFETY DEVICE | FORSUBCUTANEOUS INJECTION I||I| | Ten08mLSyringes sanofi-avents US. LLC \xe2\x80\x98 3 0075=2912=0" | Bridgewater, N} 08807 ASANOFI COMPANY \xc2\xa92013 | origin Singapore SANOFING | sonm (_ stuks g uaL NOUDINTSQOIVLIDANS 301 7 DINIO ALIVS VWLV HLIW SIBNRAS 3500 TTONIS . AINo Xy g0i0zL (ww://wm o) XON3AO01 Lozisz S0 | (enaxaparin sodium injection) Directions for Use of Lovenox | Single Dose Syringe with Awtomatic Safety Device: 1. B e el skl [~ 4. Orening e st iy by puling A svigt ot rom youand over, e yinge 1 adusting acvae e ey Ssons ine doe s e, 1 b iy g e | s sdusment s be Aunger rod T\xe2\x80\x99 g Gone pror o et he focive docwe wil au HUSEERE | Be heand 1o conm e 120mg0.8m S sy dome o | | ot LOVENOX\xc2\xae /zwwp\xef\xac\x82\xef\xac\x82\xef\xac\x82mdmmlm\xef\xac\x82m} | ot | I I weomy | L SINGLE DOSE SYRINGES WITH | AUTOMATIC SAFETY DEVICE | | FORSUBCUTANEOUS INJECTION | i | | The ey e cn rly be st one the e+ The sty souk o e sl asbenempid Acvatan cf he sty e may case rininal . | S e ey Sy ST sl B e | Temoinghe nede o the ants sk il orening 1t dowtwards vy rom yousell and Dot epce the el ikt fctn. oter. Area reserved for Serialization GTIN: SN: Lot: Exp: Datamatrix code'
5017a927-2a24-4f27-89f9-27c805bf7d59_401_8.jpg b'NoCO075291501 LOVENOX\xc2\xae (enoxaparin sodlum injection) 1 50mg/1 mL - 4 Lovenox\xc2\xae (enaxaparin sodium injection) oty Fach LOVENOX\xc2\xae Syringe ~ contains 150mg.enoxaparin sodium injection derived from porcine intestinal mucosa in Water for Injecton. Dosage and Administration: For sub- cutaneous injection. See package insert for dosage information and directions for use. Each 0.02mL graduation equals 3mg enoxaparin sodium injection. WARNING: Keep out of reach of children. Store_at 25\xc2\xb0C (77" permitted to 15-30\xc2\xb0C (59-86\xc2\xb0F) [see UsP Controlled Room Temperature]. Rx ONLY SINGLE DOSE SYRINGES WITH AUTOMATIC SAFETY DEVICE | FOR SUBCUTANEOUS INJECTION Ten 1mL Syringes DI AL SIVAOLNY HLIM SI9RMLS 3500 1ONIS AINO X4 Lovenox\xc2\xae | e i irections for Use of Lovenox || Singie Doe Syrnge vith Automatic sfey Device: T | SANOFIG 5 0075-2915-01 1 L saBupks TwL waL sanofi-aventis U.S. LLC Bridgewater, N} 06807 ASANOF] COMPANY \xc2\xa92013 Origin Singapore 50124710 ~ NOLDIINTSQOINVLNENS 404 \xe2\x80\x94 (il anpes oo XON3AO1 wLRDGL Losiszsnoo . koo e et ety byl 1 sl of e 1 Shosing e de s e e e s st b Sone 0 gt e doe o the fecve e il et 2 usig_sandard ngue, pishing the phnge 5 0 bokom of Thesinge 3. Remore the singe fom he o s lzeoog vourngeron the phnger | o * The st sysem can ol he e anc h singe: o e |+ et of e ey e st e done ny e removing e necle o e pents hin oot epcethe e sie ferjcion. GTIN: SN: Lot: Exp: Datamatrix code Skt vt S coianer Thesenysysemshoukd ot he sz, * Aciation of the saey stem may e mininal Skt of . For opiml ety sctvae re ssem 4. Ornting the el uay from you andcibos, St e ety s by iy g e | Plnger ad The e fri o o | E S Immedialy dipase of e g i he et NoCa075291501 LOVENOX\' erouparin sodum nictin) 1 50mg/1 mL ai < | mxomy | SINGLE DOSE SYRINGES Wik AUTOMATIC SAFETY DEVICE FOR SUBCUTANEOUS INJECTION Ten 1mL Syringes il oenting i dovwars s om yourl snd e Area reserved for Serialization'
55df55fb-18ec-4e00-9ed0-10bba0da513b_9_10.jpg b'Unvarnished area O VIONI \xe2\x80\x98081 26E-Uonieyg QL1ST\xc2\xa5IILNIDVINHYHA LNIHHOL K panesey 8067227 SN PlOYASNOY 10} PapUBIU] J0U S| JBUIBIU0D SIY | \xe2\x80\x9cuopeuwoju Buquosaid Buifuedwoage sag :afiesog ensf NSO JUBISISAI-PIIYO UM Jaurejuoo juelsisal-1ybi \xe2\x80\x98b e ul esuadsig \xe2\x80\x98JBay 8AISSaOXa pue aimsiow \xe2\x80\x98Wb wouj 198304 [ainesadwa] wooy PaJj0JIu0) dSN 885] (4,98 01065) Do0E 01 oS | 01 papuLIad SUOISINOXa {40/ 01 o89) 9s5Z 01 c0Z 12 21015 \xe2\x80\x9cUBIPIYP 40 4Ll 3} 10 SBNIP 12 pue siyy daey \xe2\x80\x9cgujoRoouiu B g}, 0} JusleAInba dSN \xe2\x80\x98apuojyo0ipAy aujjakooulpy :surejuoa ajnsde yoe3, 8 = B 3 S &= < > g8 & b T s= S g8 3 = =l @\xc2\xae s = \xe2\x80\x94 2e \xc2\xa9 = e a 28 = = 3 = \xe2\x80\x94 0 eEs - ) \xc2\xa75 r..uh - 28 8 Q o = % E 2 8= @ (=] = N M.m F EB = \xc2\xa3= = S & g =ExXo \xc2\xa35 o oo .'
55df55fb-18ec-4e00-9ed0-10bba0da513b_9_6.jpg b'\xc2\xa3 500 Capsules NDC 13668-484-05 Minocycline Hydrochloride Capsules, USP 100mg* " PHARMACIST: Dispense the accompanying Patient Information Sheet to each patient. ibing information. 58 2 t intended for \\e \' s = 8 g 3 \xc2\xa5 = g 2 /< sule contains: Minocydline hydrochloride, USP PHARMA North Brunswick, NJ 08902 torrent\xe2\x84\xa2 wanutactured by: ohm Laboratoris Inc 13668-484-05 Manufactured for: TORRENT PHARMA INC., Basking Ridge, NJ 07920 * Each N 3'
55df55fb-18ec-4e00-9ed0-10bba0da513b_9_7.jpg b'N/I /\xe2\x80\x98 - BAJE SiUseA UoU o T = / 2 13668-484-50 zo 010N SO DNV INHED L0 B owSun o Aapomponwen oo | oo Ouguosaid buyueducooe 2o :afesog jensn anestrg u el aNSSEOXa PUPAINSIOW npesadusa wooy pi asn 5] 4098 0 o SIS0 (oL AUI0UIK Suleluoa apnsdes e . = = S > = NDC 13668-484-50 Minocycline Hydrochloride Capsules, USP PHARMACIST: Dispense the accompanying Patient Information Sheet to each patient. 50 Capsules'
55df55fb-18ec-4e00-9ed0-10bba0da513b_9_8.jpg b'] 02620 PN \xe2\x80\x983091 DupSeg 0N VWAYHd LNFUHOL 0) Bamaeinuei EDRED L HOTNO SIED SN \xe2\x80\x982PUIONO0IPAY SUOAIOUIN :SulEIuo3 a|nsided Y3 . 8 > 2. = s :E 2 e S8 8 @\xc2\xae8 F \xc2\xa3= g g5 2 e.us g8 = g8 mnr \xc2\xa32 i -_\xe2\x80\x94 - 82 o= 8 25 22 : DOS = = o2 5E N [\xe2\x80\x94 =] S\xc2\xa2g S EBT = \xc2\xa3< = > (C zs E=TO \xc2\xa3s 3 13668-484-05 2'
55df55fb-18ec-4e00-9ed0-10bba0da513b_9_9.jpg b'Unvarnished area sz juaio} uosard buluedu 000k sag. whesoq fens P Yy Jueico U asuadsg ansop WEISE wesisa 168y anssaona PUB aINISIOW WO W0 9810k PRI 000 d ST S] (4,98 0} o6S) 406 018 0} payuad sUojs Nxa (4L 04289) 052 0} 02 18 31018 B 00} 0} WafeAnbe dsf) \xe2\x80\x98spHOLOpAY auloAoou :suleiuoa ajnsdea yoe3, Rx only 50 Capsules NDC 13668-484-50 Minocycline PHARMACIST: Dispense the accompanying Patient Information Sheet to each patient. Hydrochloride Capsules, USP 7 e'
5accc7a5-8209-4680-b0ae-2a6963500419_973_6.jpg N/A
5accc7a5-8209-4680-b0ae-2a6963500419_973_7.jpg b'Picato" Al umrat Picato\xc2\xae inganol mebutate) gel 0.05% o g e'
5accc7a5-8209-4680-b0ae-2a6963500419_973_8.jpg N/A
5d378add-f13d-40f2-99dc-0f2340ab44b7_766_10.jpg b"TIROSINT\xc2\xae - SOL (levothyroxine sodium) Oral Solution 6 pouches x 5 ampules NDC 71858-0150-5 TIROSINT\xc2\xae - SOL (levothyroxine sodium) Oral Solution For Oral Use Only \xe2\x80\x94NOT for Inhalation, Injection or Ophthalmic Use <> Rx Only 6 pouches x 5 ampules Manufactured for 18SA Pharma Inc by: 185A It Bochimiaus SA, 915 Pambio-Noranco, Switerkind Distibuted by 18SA Pharma b, Persippany, NJ 07054 Tl 800587.3513 sejndue g x sayanod 9 UoIN|OS [BIO (WNIPOS JUIXOIAYIOAS]) 710S - o LNISOYIL Description: Each 1 mlampulo containg 150 meg levothyroxine sodium, storage: Store 3t 25\xc2\xb0C (77\xc2\xb0F); excursions permitted 1o 15\xc2\xb0-30\xc2\xb0C. (59-86\xc2\xb0F). Storo ampules in the pouch unil ready <o use. Once the pouch ' opened, use ampules within 15 days. Usual Dosage: See packag nser fr dossge information For Oral Use Only ~NOT for Inhalation,Injection or Ophithalmic Use. Ses package insertfor complete nformation Temper-Evident: For your protecton, do notuse f pouches are tom, opened or incompletely sealed. KEEP THIS AND ALL DRUGS. |OUT OF THE REACH oF chILDREN. T | | | | | Direction for Use: | | | | | | | P |"
5d378add-f13d-40f2-99dc-0f2340ab44b7_766_6.jpg b'sejnduwe g x sayanod g TIROSINT\xc2\xae - SOL (levothyroxine sodium) Oral Solution 6 pouches x 5 ampules NDC 71858:0130-5 TIROSINT\xc2\xae - SOL (levothyroxine sodium) Oral Solution For Oral Use Only \xe2\x80\x94NOT for Inhalation, Injection or Ophthalmic Use R\xc2\xab Only & poliches b ampriles @ Manufactured fo IBSA Pharma Inc by 185A Inss Bochimiaus SA, 6915 Pambio-Norancs, Swizerkind Distibuted by: 1BSA Pharma b, Persippany, NJ 07050 Tl 800567.3513 70S - oLNISOYIL uo1IN|OS [RIQ (WNIPOS JUIXOIAYIOAS]) Description: Each 1 ml ampulo containg 100 meg levothyroxine socium, storage: Stors 3t 26\xc2\xb0C (77\xc2\xb0F) excursions permitted to 15\xc2\xb0-30\xc2\xb0C. (59-36\xc2\xb0F). tore ampules n tha pouch uni ready <o use. Once the pouch s opened, use ampules within 15 days Usual Dosage: See package insart for dosage information. For Oral Use Only ~NOT for Inhalation,Injection or Ophthelmic Use, Ses package insstfor complete nformation. Tomper-Evident: For your protection, do notuse f pouches are tom, opened or incompletely seoled. KEEP THIS AND ALL DRUGS. 0UT OF THE REACH oF chILDREN. T | | | | | Direction for Use: | | | | | | |'
5d378add-f13d-40f2-99dc-0f2340ab44b7_766_7.jpg b'TIROSINT\xc2\xae - SOL (levothyroxine sodium) Oral Solution 6 pouches x 5 ampules NDC 71858-0135-5. + TIROSINT\xc2\xae - SOL (levothyroxine sodium) Oral Solution For Oral Use Only \xe2\x80\x94NOT for Inhalation, Injection or Ophthalmic Use Rx Only 6 pouches x 5 ampules @ 1 Manufactured for IBSA Pharma Inc by: 18SA It Bochimiaus SA, 6915 Pambio-Noranca, Swizerkind Distibuted by: 18SA Pharma b, Persippany, NJ 07050 Tl 8005573513 Dscription: Each T mlampule containg 112 meg levothyroxine sodium. storage: Ususl Dosage: Sea packag insert fo dossge informton sejnduwe g x sayanod g For Oral Use Only\xe2\x80\x94NOT for Iahelation, nection or Ophthelmic Use. See package nser for complata information. Tamper-Evident; For your protection, do not use i pouches are torm, apaned or incompletely seoled. 10S - eLNISOYIL KEEP THIS AND ALL DRUGS. |OUT OF THE REACH |OF CHILDREN. uoIN|OS [BIO (WNIPOS JUIXOIAYIOAS]) T | | | | | Direction for Use: | | | | | | |'
5d378add-f13d-40f2-99dc-0f2340ab44b7_766_8.jpg b'TIROSINT\xc2\xae - SOL (levothyroxine sodium) Oral Solution & pouches x 5 ampules NDC 71858-0140-5 TIROSINT\xc2\xae - SOL (levothyroxine sodium) Oral Solution For Oral Use Only \xe2\x80\x94 NOT for Inhalation, Injection or Ophthalmic Use <> R Only 6 pouches x 5 ampules Manufactored for IBSA Pharma Ic by: 1BSA It Siochimiaus SA. 915 Pambio-Norancs, Switzerknd sejndue x sayanod 9 uonN|OS [RIQ (WNIPOS JUIXOIAYI0AS]) 10S - o LNISONIL Doscription: Each 1 miampul containg 125 meg levothyroxine sodium, Storage: Store at 25\xc2\xb0C (77\xc2\xb0F); excursions permitad to 15\xc2\xb030\xc2\xb0C (89-26\xc2\xb0F). Store ampules in the pouch uncl ready o use. \xe2\x80\x98Once the pouch s openad, use ampules withn 15 days. Usust Dosage: See package insert for dosage information Diraction for Use: For OralUse Only - NOT for Inhalaton, Injection or Ophihalmic Use. See package nsert for complete information. Tomper-Evident: For your protaction, do not use f pouches are tor, opened or incomgletely seoled [KEEP THS AND ALL DRUGS| 0UT OF THE REACH o chiLoREN. T'
5d378add-f13d-40f2-99dc-0f2340ab44b7_766_9.jpg b'L o ol TIROSINT\xc2\xae - SOL (levothyroxine sodium) Oral Solution 6 pouches x 5 ampules NDC 71858-0145-5. TIROSINT\xc2\xae - SOL (levothyroxine sodium) Oral Solution For Oral Use Only \xe2\x80\x94NOT for Inhalation, Injection or Ophthalmic Use Rx Only & pouches x 5 ampules @ Manufactured for 18SA Pharma Inc by: 18SA It Bochimicus SA, 915 Pambio-Norsnco, Swizerkind Distibuted by: 18SA Pharma b, Persippany, NJ 07050 Tl 800587.3513 sejndue g x sayanod 9 10S - eLNISOYIL UoIN|OS [RIQ (WNIPOS JUIXOIAYIOAS]) Description: Each 1 mlampul containg 137 meg levothyroxine sodium. storage: Store 3t 25\xc2\xb0C (77\xc2\xb0F) excursions permitted to 15\xc2\xb0-30\xc2\xb0C. (59-36\xc2\xb0F). Store smpules n the pouch unil ready <o use. Once the pouch s opaned, se ampules withn 15 days. Ususl Dosage: Seca packags nser for dossge information. Direction for Use: For Oral Use Only \xe2\x80\x94NOT for[ahelation,Injection or Ophthalmic Use. See package nsert for completa nformaton. Tamper-Evident; For your protection, do notuse f pouche are tom, apaned or incompletely secled. KEEP THIS AND ALL DRUGS. |OUT OF THE REACH |OF CHILDREN.'
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_10.jpg b'2 Single-Use Prefilled Syringes HUMIRA adval\xe2\x80\x99imvur\xe2\x80\x98nab FOR SUBCUTANEOUS ljSE.ONLV ATTENTION PHYSICIAN: Each patient is required to receive the enclosed Medication Guide. Needle Cover for Syringe May Contain Dry Natural Rubber. The entire cartonis to be dispensed as a unit. Return to physician if dose tray seal is broken or missing. www.HUMIRA.com W To Open NDC 0074-9374-71 NOT FOR SALE This carton contains: * 2 dose trays (each containing 1 single-use prefiled syringe with 1/2 inch length fixed needle) * 2 alcohol preps * 1 Medication Guide 1 package insert Rx only 1 Instructions for Use " abbvie'
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_16.jpg b'Donotacceptif sealontop of cartonis broken or missing. One40mg Vial NDC 0074-3797-01 Humira\xc2\xae Adalimumab 40 mg/0.8 mL | | | | | | For Subcutaneous Use Only | Single-Use Vial i | | | | | | | | i | | | | | | \\ Discard Unused Portion | | i | | l For Institutional Use Only ATTENTION PHYSICIAN: Each patient is required to receive the enclosed Medication Guide Rxonly'
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_17.jpg b'NDC 0074-6347-02 2 Single-Use Prefilled Syringes H UMIRA\xc2\xae This carton contains: Medication Guide for patient enclosed. . a d a I I m u m a b Needle Covers for Syringe May Contain Dry Natural Rubber. Carton contains 2 dose trays, 2 alcohol preps, 1 package insert, 1 Medication Guide and Instructions for Use. 1 0 m gl 0.2mL Each dose tray contains 1 single-use prefilled syringe with FOR SUBCUTANEOUS USE ONLY 1/2 inch length fixed needle. The entire carton is to be dispensed as a unit. \xe2\x80\x98T\xe2\x80\x98 \xe2\x80\x98T\xe2\x80\x98 Return to pharmacy if dose tray seal is broken or missing, www.HUMIRA.com Rx only Please see package insert for full prescribing information. W To Open abbvie'
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_18.jpg b'2 Single-Use Prefilled Syringes NDC 0074-0243-02 S 29 7 HUMIRA\xc2\xae adallm umab 0] mg/0.4 mL syringe FOR SUBCUTANEOUS USE ONLY'
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_19.jpg b'1 Single-Use Prefilled Pen NDC 0074-0554-01 29 7 HUMIRA\xe2\x80\x99PEN - 2 adalimumab 40 mg/0.4 mL FOR SUBCUTANEOUS USE ONLY ATTENTION PHARMACIST: Each patient is required This carton contains: to receive the enclosed Medication Guide. \xc2\xab 1 dose tray (containing 1 single-use prefiled pen with 29 gauge /2 inch length fixed needle) The entire carton is to be dispensed as a unit. * 2 alcohol preps. Return to pharmacy if dose tray seal is broken or missing. s 7 Modication Guido. 1 package insert \xc2\xbb 1 Instructions for Use: Rx only www.HUMIRA.com obbvie W ToOpen'
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_20.jpg b'2 Single-Use Prefilled Pens NDC 0074-0554-02 7HUMIRA\xe2\x80\x99PEN e 4 adallmumab 40 mg/0.4 mL FOR SUBCUTANEOUS USE ONLY ATTENTION PHARMAGCIST: Each patient is required This carton contains: to receive the enclosed Medication Guide. * 2 dose trays (each containing 1 single-use prefiled pen The entire carton is to be dispensed as a unt. vl 29ca gelii2inctiegihifednesde) + 2 alconol preps Retum to pharmacy if dose tray seal is broken or missing. * 1 Medication Guide \xc2\xab 1 package insert www.HUMIRA.com * 1 Instructions for Use. Rx only. W ToOpen obbvie'
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_26.jpg b"Pediatric Crohn\xe2\x80\x99s Disease Starter Pack \xc2\xbb FOR PEDIATRIC PATIENTS < 40 kg 7HUMIRA\xe2\x80\x99 adalimumab 2 Single-Use Prefilled Syringes FOR SUBCUTANEOUS USE ONLY One 80 mg/0.8 mL One 40 mg/0.4 mL NDC 0074-0067-02 29 Gauge Needle Medication Guide for patient enclosed. Each 80 mg/0.8 mL Sterile Single-Use Prefilled Syringe Contains: Adalimumab. Mannitol.. Polysorbate 80.. Water for injection. Each 40 mg/0.4 mL Sterile Single-Use Prefilled Syringe Contains: 80mg 0.8mg The Adalimumat 40mg Mannitol. . 16.8 mg Polysorbate 80.. 04 mg Water for injection. www.HUMIRA.com V1o Open Contains no preservatives. No U.S. standard of potency. Needle cover for syringe is not made with natural rubber latex. Carton Contains: 2 dose trays (each containing 1 single-use prefilled syringe with 29 gauge 1/2 inch length fixed needie) 2 alcohol preps 1 package insert 1 Medication Guide 1 Instructions for Use '@ entire carton is to be dispensed as a unit Do not accept if seal is broken or missing. Return to pharmacy if dose tray seal is broken or missing. Rx only aobbvie"
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_6.jpg b'2 Single-Use Prefilled Syringes NDC 0074-3799-02 HUMIRA adalimumab 40 mg/0.8 mL Syringe FOR SUBCUTANEOUS USE ONLY ATTENTION PHARMACIST: Each patient is required This carton contains: IS Ll Medlcahon [t L dose trays (& [eonlETOR B SRICA ] =] Needle COVerforsyrInge L= COniam Dry syringe with 1/2 inch length fixed needle) Natural Rubber. PRSI The entire carton is to be dispensed as a unit. * 1 Medication Guide Return to pharmacy if dose tray seal is broken or missing. ~ * AN E RN LN h CRNIS T S gV g www.HUMIRA.com W ToOpen obb'
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_7.jpg b'Pediatric Crohn\xe2\x80\x99s Disease Starter Pack \xe2\x80\x94 \xc2\xbb FOR PEDIATRIC PATIENTS <40 kg HUMIRA adalimumab 3 SINGLE-USE PREFILLED SYRINGES FOR SUBCUTANEOUS USE ONLY 40 mg/0.8 mL Each Sterile Single-Use Prefilled Syringe Contains: Medication Guide for patient enclosed. Adalimumab. 40mg Needle Cover for Syringe May Contain Dry Natural Rubber. Sodium chioride. 4.93mg Carton Contains: Monobasic sodium * 3 dose trays (each containing 1 single-use prefiled Syringe phosphate dinydrate........... 069 mg with 1/2 inch length fixed needie) Dibasic sodium * 4 .alcohol preps phosphate dihydrate.... .122mg \xc2\xab 1 Package Insert Sodium citrate... 024mg * 1 Medication Guide Citic acid monohydrate. 1.04 mg * 1 Instructions for Use Mannitol.. 9.6mg The entire carton is to be dispensed as a unit. Polysorbate 80.. 0.8mg Do not accept if seal is broken or mis: 9. Water for injection. Return to pharmacy if dose tray seal is broken or missing. \xe2\x80\x98Sodium hydroxide added as nece to adjust pH. . ! www.HUMIRA.com Contains no preservatives. No U.S. standard of potency. Rx only abbvie'
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_8.jpg b"2 Single-Use Prefilled Syringes HUMIRA adalimumab 40 mg/0.8 mL Syringe FOR SUBCUTANEOUS USE ONLY ATTENTION PHYSICIAN: Each =10 ] to receive the enclosed [T \xe2\x82\xac 3 Needle Cover for Syringe May Con'laln Dry Natural Rubber. The entire carton is to be dispensed as a unit. Retum to physician if dose tray seal is broken or missing. www.HUMIRA.com W To Open LT 2By IR NOT FOR SALE QLY RIS * 2 dose trays (each containing 1 single-use prefilled BV R RV e e R eyt 5] PRl e * 1 Medication Guide * 1 package insert T * 1 Instructions for Use = P obbvie"
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_9.jpg b'2 Single-Use Prefilled Syringes HUMIRA\xc2\xae adalimumab FOR SUBCUTANEOUS USE ONLY ATTENTION PHARMACIST: Each patient is required to receive the enclosed Medication Guide. Needle Cover for Syringe May Contain Dry Natural Rubber. The entire carton is to be dispensed as a unit. Return to pharmacy if dose tray seal is broken or missing. www.HUMIRA.com W ToOpen NDC 0074-9374-02 This carton contains: * 2 dose tra%s (each containing 1 single-use prefilled syringe with 1/2 inch length fixed needle) * 2 alcohol preps * 1 Medication Guide * 1 package insert Rx only * 1 Instructions for Use . abbvie'
60e9397e-83b9-489e-9683-6f87e458bbaa_430_6.jpg b"o N o ~ N '~ ~ N 3 Each uncoated tablet contains: Glimepiride USP 8 mg Dosage and Administration: See package insertfor dosage information WARNING: Keep out of reach of chidren Pharmacist: Dispense in well closed container with child-resistant closure Store at 20\xc2\xb0-25\xc2\xb0C (68\xc2\xb0-77\xc2\xb0F) [see USP Controlled Room Temperature] Varnish free arca for batch details NDC 42571-105-01 GLIMEPIRIDE TABLETS, USP ONCE A DAY Rx Only 100 Tablets Area for Pharma code Manufactured by: Micro Labs Limited 60a-403 722, INDIA M.L:651 Manufactured for: Micro Labs USA Inc. Basking Ridge, NJ 07920 Artworkcode"
60e9397e-83b9-489e-9683-6f87e458bbaa_430_7.jpg b"o o o i~ N '~ < 3 Each uncoated tablet contains: Glimepiride USP 1 mg Dosage and Adminisiration: See package insert for dosage information 'WARNING: Kezp out of reach of chilcren. Pharmacist: Dispense in well closed container with child-resistant closure. Store at 20\xc2\xb0-25\xc2\xb0C (68\xc2\xb0-77\xc2\xb0F) se2 USP Controlled Room Temperature] Vanish free arca for batch details I NDC 42571-100-01 GLIMEPIRIDE TABLETS, USP ONCE A DAY Rx Only 100 Tablets Area for Pharma code Manufactured by: RA CHEM PHARMA LIMITED Hyderabad - 500 076, INDIA. M. L. No.: 23/RRIAP/2007F/R Artworkcode Manufactured for: Micro Labs USA Inc. Basking Ridge, NJ 07920"
60e9397e-83b9-489e-9683-6f87e458bbaa_430_8.jpg b"o o Each uncoated tablet contains: Glimepiride USP 2 mg Dosage and Administration: See package insert for dosage information. 'WARNING: Kezp out of reach o chilcren. Pharmacist: Dispense in well closed container with child-resistant closure. Store at 20\xc2\xb025\xc2\xb0C (68\xc2\xb0-77\xc2\xb0F) se2 USP Controlled Room Temperature] Varnish free area for batch details NDC 42571-101-01 GLIMEPIRIDE TABLETS, USP ONCE A DAY Rx Only 100 Tablets Area for i Pharma code Manufactured by: RA CHEM PHARMA LIMITED Hyderabad - 500 076, INDIA. M. L. No: 23/RR/APR007/F/R Manufactured for: Micro Labs USA Inc. Basking Ridge, NJ 07920"
60e9397e-83b9-489e-9683-6f87e458bbaa_430_9.jpg b'42571 10301|| Each uncoated tablet contains: Glimepiride USP 4 mg Dosage and Administration: See package insertfor dosage information WARNING: Keep out of reach of children Pharmacist: Dispense in well closed container with child-resistant closure Store at 20\xc2\xb0-25\xc2\xb0C (68\xc2\xb0-77\xc2\xb0F) [see USP Controlled Room Temperature] Vamish free area for batch details NDC 42571-103-01 GLIMEPIRIDE TABLETS, USP ONCE A DAY Rx Only 100 Tablets Area for i Pharma code | Manufactured by: RA CHEM PHARMA LIMITED Hyderabad - 500 076, INDIA. M. L. No: 23/RRIAPR007/F/R Artworkcod Manufactured for: Micro Labs USA Inc. Basking Ridge, NJ 07920'
65f56eff-4f67-4cbf-a801-a632261afc29_886_6.jpg b'= oo AU B ...,'
6909596e-4bf7-4e11-8029-b89740a30aec_560_6.jpg b"One f0mLVal Multiple-Dose Testosterone Cypionate Injection, USP 200 mg/mL [ For inframuscular use only Hospira Store at controlled room temperature 20\xc2\xb0 0 25\xc2\xb0C (68\xc2\xb0 0 T7\xc2\xb0F) see USP). Store product i this carton o protect contents from light. 'DOSAGE AND USE: See accompanying prescrbing information Each ml conains tetosterone cypionate, 200 mg. Hiso contains benzyl benzoate, 02 mL benzyl akcohol added as presenvative, 945 mg; in cotionseed of, 560 g mcumsEen | One 10mL Vial Multiple-Dose. Cypionate Injection, USP | | | Testosterone | | | 200 mg/mL i | For intramuscular use only Holpira IMPRINT AREA = - - ="
6937c596-9ca4-480e-9090-b9d8a3c271c8_13_6.jpg b'SOIQENONNY \xc2\xa2/ SieiA 3s0Q 9BUIS W Z X 6T asn snouanenu| Jog / (quyBowg) qui Z 45d Bowi o} dsn \xe2\x80\x98uonoafuj [ TEe] =T I=F | 20-412-05155 AN = \\ s Ajuo xy 90EEH0d Paricalcitol Injection, USP 10 meg per 2 mL \\_(5meg/mL) ) For Intravenous Use R auroveEDICs Rx only NDC 55150-214-02 Sterile 25 2 mL Single Dose Vials Distributed by AuroMedics Pharma LLC 278 Princeton-Hightstown Rd . Windsor, NJ 08520 Made in India Code: TS/DRUGS/132010 Rxonly NDC 55150-214-02 Paricalcitol Injection, USP 10 meg per 2 mL \\_ (5meg/mL) / For Intravenous Use Sterile 25 x 2 mL Single Dose Vials R AUROMEDICS Each mL contains: Paricacitol USP, 5 mg; propylene alycol, 30% (v} \xe2\x80\x98and alcohol, 20% (vA). Usual Dosage: See Package Insert for full prescribing information. USE ASEPTIC TECHNIQUE Remove cover from vial and cleanse stopper with antisepic Discard unused porton, Store a1 20\xc2\xb0 10 257G (68\xc2\xb0 10 77\xc2\xb0F).[See USP Controlled Room Temperature | The val stoppers are not mads with natural ubber latex'
6937c596-9ca4-480e-9090-b9d8a3c271c8_13_7.jpg b'Rx only NDC 55150-215-02 Distributed by: AuroMedics Pharma LLC " " E. Windsor, NJ 08520 Paricalcitol E - Made in India TR coce: T5i0RUGS 1372010 10 mcg per 2 mL \\ (5meg/imL) For Intravenous Use 2mL Multi Dose Vial AUROMEDICS'
6937c596-9ca4-480e-9090-b9d8a3c271c8_13_8.jpg b'o SOIqENONNY \xc2\xa2/ SIEIA 2500 BINN TW Z X 6T sls asn snousnenu Jog /[ (quBowg) \\ qui Z 15d Bowi o}, SRR (] (TR BT F=2 | 20\xc2\xb0512-05155 OGN Ajuo xy Um0 e ISR 1EEId NDC 55150-215-02 Paricalcitol Injection, USP 10 mcg per 2 mL \\_(5meg/mL) For Intravenous Use . 25 2 mL Multi Dose Vials AP AUROMEDICS Rx only Sterile 279 Princeton-Hightstown R E. Windsor, NJ 08520 Made in India Code: TS/DRUBS/132010 sl 27502 5150 |/ Rx only Sterile NDC 55150-215-02 Paricalcitol Injection, USP 10 meg per 2 mL \\_(5meg/ml) / For Intravenous Use < 25 x 2 mL Multi Dose Vials /R AUROMEDICS Each mL contains: Paricalcitol USP, 5 mcg; propylene alycol, 30% (viv): and alcohol, 20% (vA). Usual Dosage: Ses Package Insert or full prescribing information. USE ASEPTIC TECHNIQUE Remove cover from vial and cleanse stopper with antiseptic Store at 20\xc2\xb0t0 257G (68\xc2\xb0 10 77\xc2\xb0F).[See USP Gontrolled Room Temperature The val stoppers are not made with natural rubber latex'
6fe62c06-5bab-4fc8-b546-ff015a1fc40c_202_6.jpg b'6520-25 MO138\xc2\xb0dX3/101 | LL/L0""Y $50\xc2\xa30 N \xe2\x80\x98Aueddisieg U] \xe2\x80\x98ewieyq siey :Ag paanquysiq \xe2\x80\x9caanysiow pue 3y6i| woiy 133014 (4,98 ~65) 206 - .5 L 03 panLIad SUOISINIXS (4./\xc2\xa3) .57 18 310} \xe2\x80\x9cJ3UIRJUOD JuBsISal-1yb| \xe2\x80\x9cJooidpyiy> Juapirs-1aduie) pajeas e ui asuadsiq \xe2\x80\x98UIp|Iy Jo Lpeal 3 Jo 3o daayj \xe2\x80\x98uonedipaw [[e yum sy :Buiwiep PaA|OSSIP 1o paysni \xe2\x80\x98pamayd aq JON pInoys sajnsde. aseaja.-papua)xe ajejins aulydiow woyy syajed ay) \xe2\x80\x98uoljeusioul buiqinsaid buifuedwode 335 :39yS0d TYNSN! | \'s12]j2d aseaja1-papuaixa se ajeyns auiydiow Hwi og *SNIVINOD F1NSdYD HOV3 quaged yoea 0} ApPjesedas papinoid wv.:mv uonedpajy 3s :wmm__u ases|d :ISDYWHYHd 3 i 3 O F 3 - Dl g 8 @ Oa S S \xc2\xa3 =2 os s Z98\xc2\xa2 \xc2\xa3 Qw25 S e g SA5S'
6fe62c06-5bab-4fc8-b546-ff015a1fc40c_202_7.jpg b'2 __ooxom \xc2\xa38220 0 \xc2\xa2 0920-2\xc2\xa7 MO0138 \'dX3/101 | LL/L0\xc2\xb0NY 50\xc2\xa30 [N \xe2\x80\x98Aueddisied U] \xe2\x80\x98ewiey siAeldy :Ag panquasiq) \xe2\x80\x9caanysiow pue Jybi| woiy 133014 (4,98 ~65)! 206 - 5\xc2\xa7 03 PanIULIad SUOISINIX\xc2\xae {(4,/) J,ST 12 10N \xe2\x80\x9cI3UIRJUOD JUR)SIS3I-) \xe2\x80\x9cJooidp|iy> Juapirs-1aduie) \xe2\x80\x98pajess e ui asuadsi \xe2\x80\x9cualpjiy Jo yoeal! 34 Jo 1n0 daay\xe2\x80\x98uonedIpaw [je Yyim sy :burus m>>\xe2\x80\x9c "PAA(OSSIP| 10 paysnud \xe2\x80\x98pamay aq JON PInoys sajnsded, 95e3[21- papua)Xe ajeyins aulydiow woysyvRd 3y, \xe2\x80\x9cuoljewoul| Buiquosaid buikuedwonde 335 :39y50Q TYNSNI *SNIVLNOD F1NSd\xc2\xa5D HOV3! quaned yoea o} Apjesedas papinoid| 3pIng uopedIpaly asuadsip aseald :LSDYWHYHd! | \xc2\xab Extended-Release Capsules, USP | I i @\xc3\xa9 | o = S = & 60 capsules Morphine Sulfate NDC 0228-3507-06'
6fe62c06-5bab-4fc8-b546-ff015a1fc40c_202_8.jpg b'6, w90805,\xc2\xa3822 W 1920-2S MO39 "dX3/101 1 L1/L0\xc2\xb0AY +50\xc2\xa30 (N \xe2\x80\x98Aueddisieq h u| \xe2\x80\x98euwieyq siAey :Ag paanqusiq | \xe2\x80\x9caanysiow pue 3y6i| woiy 133014 (4,98 ~65) 2,06 - o5 | 03 PaRIuLIad SUOISING !(4,\xc2\xa3\xc2\xa3) JST 12 2I0IS \xe2\x80\x9c13UlejuoD Jue)sisal-Jybiy | yoosdppy> Juapirs-1aduie) \xe2\x80\x98pajeas e ul asuadsiq | \xe2\x80\x9cUBIP|IY JO Lpeal I 3y Jo 1no daey \xe2\x80\x98uonedipauu jje yum sy :burwepy : PanjossIp 10 paysnId \xe2\x80\x98pamayd aq JON pinoys sajnsden, \xe2\x80\x98aseajai-papua)xa ajey|ns aulydiow woy sp|Rd ay) . \xe2\x80\x9cuoijeuwioyuy Buiquosaid buikuedwonde 335 :39y500 TYNSN [ [s19)j2d aseajas-papuay@ se ajeyns aulydiow bwi 0oz | *SNIVINOD J1NSdYD HOV3 quaged yoes 0} pjesedas papinoid | 3pIND uopedIPa|Y asuadsip aseald :1SDYWHYHJ " | S wn sS{= mmCm 28, 25 So U M% gL 5% = \xc2\xa3339 m.:mnw 0=s8a A& =adsd'
71cf3309-e182-473c-8b0b-280cabd0e122_588_6.jpg b'6, w90805,\xc2\xa3822 W 1920-2S MO39 "dX3/101 1 L1/L0\xc2\xb0AY +50\xc2\xa30 (N \xe2\x80\x98Aueddisieq h u| \xe2\x80\x98euwieyq siAey :Ag paanqusiq | \xe2\x80\x9caanysiow pue 3y6i| woiy 133014 (4,98 ~65) 2,06 - o5 | 03 PaRIuLIad SUOISING !(4,\xc2\xa3\xc2\xa3) JST 12 2I0IS \xe2\x80\x9c13UlejuoD Jue)sisal-Jybiy | yoosdppy> Juapirs-1aduie) \xe2\x80\x98pajeas e ul asuadsiq | \xe2\x80\x9cUBIP|IY JO Lpeal I 3y Jo 1no daey \xe2\x80\x98uonedipauu jje yum sy :burwepy : PanjossIp 10 paysnId \xe2\x80\x98pamayd aq JON pinoys sajnsden, \xe2\x80\x98aseajai-papua)xa ajey|ns aulydiow woy sp|Rd ay) . \xe2\x80\x9cuoijeuwioyuy Buiquosaid buikuedwonde 335 :39y500 TYNSN [ [s19)j2d aseajas-papuay@ se ajeyns aulydiow bwi 0oz | *SNIVINOD J1NSdYD HOV3 quaged yoes 0} pjesedas papinoid | 3pIND uopedIPa|Y asuadsip aseald :1SDYWHYHJ " | S wn sS{= mmCm 28, 25 So U M% gL 5% = \xc2\xa3339 m.:mnw 0=s8a A& =adsd'
71cf3309-e182-473c-8b0b-280cabd0e122_588_7.jpg b'1] Ju/bw g0 i NOISNISNS W40 (Buediuessd) Duyoady =y s o | Fycompar \xe2\x80\x98 (perampanel) ORAL SUSPENSION a 0.5 mg/mL PR \xe2\x80\x94 [LTeyerer\xe2\x80\x94\xe2\x80\x94\xe2\x80\x94\xe2\x80\x94 P 340 mL [ S JRSe\xe2\x80\x94\xe2\x80\x94 NOISN3dSNS TvHO (eueduesad) Schuoody Dateofstopeniog__/_/_. Discard unsed porbon 90 days st st opening. D0 ot sore sbowe 3\xc2\xb0C (67 D0 ot ez, DOSAGE AND USE Sea ccompanyig prescrting mormasen 02018 Emi sostse2us 1 [\xe2\x80\x94 mowy pa (perampanel) ORAL SUSPENSION @ 0.5 mg/mL By T [P P \xe2\x80\x94\xe2\x80\x94 T (R \xe2\x80\x94\xe2\x80\x94\xe2\x80\x94 e 8 [ > JO\xe2\x80\x94 < Q'
7560c201-9246-487c-a13b-6295db04274a_826_6.jpg b'For Allegic Enesencis aphylai) EPIPENJr 2-PAK\xc2\xae (epinephrine injection, USP) Auto-Injectors 0,15 mg Fach carton contains: Two green EpiPen Jr* One grey Trainer "Auto-Injoctors Register your EpiPen Jr* Auto-Injectors at www.epipen.com (EPIPENJL\' 2-Pak " Seplce i o, St st 68 077 (epinephrine injection, USP) Aum-lnjednlso.igumg iy oSeso sy 3310 pury 0 133501 gt 04 1d 59N iy 820 a4 0 110 s0ui oo 31 Pl o roceive frea refil reminders (Mylan\xc2\xae oy s s e | e jecion, U mw\xef\xac\x81w EPIPENIr 2-PAK\xc2\xae e s'
75e96faa-545b-52d6-e053-2991aa0a8fb8_984_6.jpg b"(01)00351682132515 (17)180831 See manufacturer's um\xe2\x80\x98lmun Distributed by HE Acquishio Co.lic Mukilteo, wa 98275"
78221eab-66fd-4cd8-9c81-af52eb83671c_1_6.jpg b'i Oral Transmucosal ot 1000 meg i e'
795c13cd-e9ca-481b-9fa9-2890bdf9dac8_231_6.jpg b'(aomes tu mssaw sz aw 6 P 0D \xc2\xa2 i 31001 1 s Bty dsn \xe2\x80\x98siege] uohwoiygizy o w | wargumseom Each - coate it contalns: Aoy oyt USPoqualnt inazmomon 1 my osmizony: Ao Phama s, o 279 Prcsonsgrsiwn R it Wisor 106520 wass nnga oo TSORKGSZ2200 II||I|I III"l ls5a02hs4 20015 o eseez.542.00 woc 855264210 oy Azithromycin Tablets, USP Al cors ot it berapy 1 3 ay goss. Axomy Azithromycin Tablets, USP Al cous of it erapy I ay oss. \'DOSAGEAND USE: e scampanyg prscring moton Stor0 320257 (3 0 778 USP Contols oom Tongenin] 7 om0 Tabots 3 artonsxTrn 5o my Taba) | TS paage s st Apumcman \xc2\xa9Tas (3 Garan e 50 g Tt'
7a7ade79-0165-4e31-b84e-667416c00c7e_157_10.jpg b'sty vsi) TIROSINT\xc2\xae (levothyroxine sodium) capsules TS per capsule Swallow capsule whole. Do not <, crush, or chaw. R Only 3 blisters x 10 capsules NDC 71858-0050-4 or packaging untll ready to use <> Usual Dosage: See package insert for dosage information. Rx Only 3 blisters x 10 capsules - Tamper-Evident: <% \xc2\xa7Eg | Donotaccept ifinner blister units have been opened. SO SRk | storage: i d Store at 25\xc2\xb0C (77\xc2\xb0F); excursions permitted to 15\xc2\xb0-30\xc2\xb0C S (59\xc2\xb0-86\xc2\xb0F). (See USP Controlled Room Temperature). Protect from light and moisture. 3 == TIROSINT\xc2\xae NDC 71858-0050-4 9:8 \'\xc3\xa9 (N E & (levothyroxine sodium) capsules EEl 2 S o s 2 150 mcg \xc2\xa7 "!@ per capsule \xc2\xa7 Do not remove jual capsules from blister pac until ready to use] 5 Swallow capsule whole. Da not cut, crush, or chew. <> @ liieciuedfor A Pama nc by 1BSA Institut Biochimique SA, 6915 Pambio-Noranco, Switzerland. Distributed 18SA Pharma fnc, Parsippany, NJ 07054 -Tol. 800.567.3513 KEEP THIS AND ALL OTHER DRUGS OUT OF THE REACH OF SMALL CHILDREN 571858 00504 \xc2\xa3z \xc2\xa38 Ed0s1e'
7a7ade79-0165-4e31-b84e-667416c00c7e_157_6.jpg b'15861 (vsn) TIROSINT\xc2\xae (levothyroxine sodium) capsules LT ) per capsule Do not remove individual capsules from blister packag) \xe2\x80\x98Swallow capsule whole. Do not <, crush, or chavi Rx Only 3 blisters x 10 capsules NDC 71858-0030-4 until ready to use] <> Usual Dosage: See package insert for dosage information. Swallow capstle whole. Do not cut, crush, or chew. Ry Only 3 blisters x 10 capsules until ready to use] o TamperEvident: o8 g 25 | Donotaccept if inner blister units have been opened. % umE | storage: YageT Store at 25\xc2\xb0C (77\xc2\xb0F); excursions permitted to 15\xc2\xb0-30\xc2\xb0C S (59\xc2\xb0-86\xc2\xb0F). (See USP Controlled Room Temperature). Protect from light and moisture. e TIROS NT\xc2\xae NDC 71858.0030-4 il 8 | I g e & (levothyroxine sodium) capsules N S o s 2 \xc2\xa3 4 5 e <> \xc2\xa9 e A B e, tetnd Distributed by 18SA Pharma fnc, Parsippany, NJ 07054 -Tol. 800.567.3513 DRUGS OUT OF THE REACH |II|| OF SMALL CHILDREN 571858 00304 z608xCs \xc2\xa308/5Y \xc2\xa3 10518'
7a7ade79-0165-4e31-b84e-667416c00c7e_157_7.jpg b'2ss6s vsn) TIROSINT\xc2\xae NDC 71858:0035-4 (levothyroxine sodium) capsules 112mcg per capsule Do not remove Ry Only 3 blisters x 10 capsules until readly to use] Swallow capsulle whole. Do not cus, crush, or ch Usual Dosage: See package insert for dosage information. Rx Only 3 blisters x 10 capsules o TamperEvident: 22 P2x [ Donotacceptif inner blister units have been opened. BE ynf | storage: nage Store at 25\xc2\xb0C (77\xc2\xb0F); excursions permitted to 15\xc2\xb0-30\xc2\xb0C b (59\xc2\xb0-86\xc2\xb0F). (See USP Controlled Room Temperature). Protect from light and moisture. = \xc2\xae 2 . = NDC 71858-0035-4 H 2 | TIROSINT E 3 (levothyroxine sodium) capsules . S 3 g 5 AR T s e per capsule \xc2\xa3 \xc2\xa3 vl il whole, Do TEt . Sl Sreha <> 4 > Ve iorBsA Prama ncby: 1BSA Institut Biochimique SA, 6915 Pambio-Noranco, Switzerland. Distributed B ot Parsopany. N 07054 Tl 800:587.3513 KEEP THIS AND ALL OTHER DRUGS OUT OF THE REACH OF SMALL CHILDREN 71858 00354 g > z & 410518'
7a7ade79-0165-4e31-b84e-667416c00c7e_157_8.jpg b'TI ROSINT\xc2\xae NDC 71858-0040-4 (levothyroxine sodium) capsules 125mcg per capsule Do not remove ual capsules from blister packaging until ready to use] Swallow capsule whole. Do not <, crush, or chaw. Rx Only | 3blisters x 10 capsules | Usual Dosage: See package Insert for dosage information. Tampen-Evident: Do not accept f inner blister units have been opened. Storage: Store at 25\xc2\xb0C (77\xc2\xb0F); excursions permitted to 15%-30\xc2\xb0C (59\xc2\xb0-86\xc2\xb0F). (See USP Controlled Room Temperature). Protect from light and moisture. \xc2\xa3z gs se9v d (61 9bueIQ 20z oy 6z nlg e S0t v TIROSINT\xc2\xae NDC 71858-0040-4 (levothyroxine sodium) capsules 125 mcg ki H 4 b Bow szl per capsule \xc2\xbb LNISOYIL Do not remove ual capsules from blister packaging until ready to use] Swallow capsule whole. Do not cut, crush, or chew. Rx Only 3 blisters x 10 capsules Sajnsciea (wnipos suoiions]) @ epfectreg oo phams by 18R it Siochmicue SA, 915 Pambio-Noranco, Sitzerand KEEP THIS AND ALL OTHER Disuted by 18SA Pharma fnc, Parsippany, NJ 07054 -Tol. 800.567.3513 DRUGS OUT OF THE REACH III" || OF SMALL CHILDREN 571856 00404 s EdU0s1e'
7a7ade79-0165-4e31-b84e-667416c00c7e_157_9.jpg b'vesey i) NDC 71858-0045:4 TIROSINT\xc2\xae (levothyroxine sodium) capsules 137 meg per capsule Do not remove i ual capsules from blister packaging until ready to use] Swallow capsule whole. Do not <, crush, or chaw. Rx Only | 3blisters x 10 capsules | Usual Dosage: See package insert for dosage information. Do not remove ual capsules from blister packaging untl ready to use] Swallow capsule whole. Da not cut, crush, or chew. o Tamper-Evident: o8 i 25 | Donotaccept if inner blister units have been opened. 38 x w& | storage: SRR Store at 25\xc2\xb0C (77\xc2\xb0F); excursions permitted to 15\xc2\xb0-30\xc2\xb0C S (59\xc2\xb0-86\xc2\xb0F). (See USP Controlled Room Temperature). Protect from light and moisture. T | \xc2\xae 2. = NDC 71858-0045-4 ol - 2 | TIROSINT ] Y (levothyroxine sodium) capsules Ll : 2 137 mcg \xc2\xa7 "!@ per capsule Rx Only 3 blisters x 10 capsules @ e oA rama e 1BSA Institut Biochimique SA, 6915 Pambio-Noranco, Switzerland. KEEP THIS AND ALL OTHER Disributed b 18SA Pharma fnc, Parsippany, NJ 07054 -Tol. 800.567.3513 DRUGS OUT OF THE REACH I|I| OF SMALL CHILDREN 571858 00454 1 Z 8 \xe2\x82\xac 10518'
7fc95729-2f5d-4d5c-b26c-3a13854f73e3_748_6.jpg b'Each ol diieyaing it catin 5 mgof Zimipn, USP. Zolmitriptan Orally Disintegrating Tablets, USP Usual Dosage: Saopacage nsetor ot e s Phenyhetonurics: Contans Pranyaanne 501mg Por Tt Stre w2025 680 (528 USP Contoted Roon Tamperatrs], Potctom ghtard e KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHLOREN, e \xc2\xae lomaion rosdedspasy e puas Recaly 3(1x3) Unit-dose tablets Zomitipan Oraly Disiagratng Tablts USP'
85d3ce8b-8966-45d9-bdaf-f6f0475096e1_415_6.jpg b"o Venlataxine Hydrochloride Extended-Release Capsules USP PAARAGST,Dipasa e st e provisss s s e e 7 AuRoBINDO 10601y 010110 vt s ot EEISTIELE oo ong Venlafaxine Hydrochloride Extended-Release Capsules USP 150 mg* i e evmi e ke \xc2\xa3 i ety z sz 3 [ \xe2\x82\xacI % ' dsnsamsde) ase: U201 MK @ s sainsdeg asearay: dsn sapisde) asealay-papualy M UONIOIDAY AU Xeje[UD] st sm st"
8f549d95-985b-f783-1ebb-ef57bd2ecb05_883_10.jpg N/A
8f549d95-985b-f783-1ebb-ef57bd2ecb05_883_6.jpg N/A
8f549d95-985b-f783-1ebb-ef57bd2ecb05_883_7.jpg b'A\\ | FENTORA" @ Gt s e GO e'
8f549d95-985b-f783-1ebb-ef57bd2ecb05_883_8.jpg N/A
8f549d95-985b-f783-1ebb-ef57bd2ecb05_883_9.jpg N/A
90b94524-f913-48b3-3771-7b2fcffd888a_123_6.jpg b') cotwices 1600 MY i B ==t e'
9d265c44-32fe-4962-a1b1-aacb64b6e82d_508_6.jpg b'wa an Ze oueon wye ujssuedsy "Wy woy ooy faumpsdus] woog poyonuog g5 o) o 01 591,501 % O WOPIND 04200110 10 dooy Bt iy Buqosaid Buueduosos 035 a5 pue oBEsoq 450 Tolopen Bu 05 suuc0 o o3 8omg NDC 50742-180-10 Nadolol Tablets, USP Manutactured for: Ingenus Prarmaceuticals LLO Orlando, FL32839-8408 Manutactured by: Ingenus Pharmaceutcals NJ, LLC Faifield, NJ 07004 18010 v1/06-2017'
a0949773-c75f-4ef0-a69c-1abd978340d0_651_6.jpg b"\xe2\x80\x9cUBIDUD o Kemy GooY SISy PO 10N 51 deg \xe2\x80\x9c0an 1 1263 onjound o1 ded penu| uosuf eBeoEd e unejned OY4M pu S1EBoInbsss UeyqI0s foyoof Ko XM O} (5650\xc2\xb00) B G0 SPIOUAIPUEIN] SUE0D WEIE LoBT VGRSV eI L T RN Y BT f T e 0/0900 dsn \xe2\x80\x98uaunuiQ apijousipuen|4 ueipiod i 00-020-0L19} OON \xc2\xb0qny 6 09 Flurandrenelide Ointmart, USP Cordran (010 T A PP FOR EXTERNAL USE ONLY~ NOT FOR USE IN THE EYES Store at 20\xc2\xb0 10 25\xc2\xb0G (68\xc2\xb0 o 77\xc2\xb0F) with excursions parmitted to 15\xc2\xb0 10.30\xc2\xb0C (59\xc2\xb0 to B6\xc2\xb0F) [Sea USP conirollad room temprature]. Kasp Gontaine: Tightly Closed Fe ks oo, ALl oo . 1636 16110'02660 i"
b7d23ac2-e776-9f62-3290-c64c2d6eb353_850_6.jpg b'NDC 59011-276-60 8 09-92\xc2\xa22-L106S _m_ g0-216\xe2\x82\xac0\xc2\xa2\xe2\x82\xac 1\xc2\xa3\xc2\xa5E-10690 L9 \xe2\x80\x98Plojwerg *d"] ewlieyd enpind (4:98-:68) 008G} usamlag pajiwied suoIsINOXe ((d,//) D.62 1e 2101 \xe2\x80\x9cJouleuoo juelsisal-ybi| ybiy e ul ssuadsig e 3 = \xe2\x80\x94K O D M > JMA|Q g2 | \xc2\xa3 93 W S5 gEs]o0 o8 = Em o 855| x\xc2\xa3\xc2\xa3 5 \xc2\xa3 ...\xe2\x80\x98m..n_w m ESE DnW.m a.US g2 0w o = \xc2\xa9 s = o D1ce ges| 2% o9 gcg o o c3S geZ| 85 o FEE| o + 2 amm OO Sl 8 =0 sce =58 bWuW o T S2s] 0 020 IS5 E8E| \xc2\xa9 =88 g8 22| 5 Scs < = o \xc2\xb0 s T4 = 12838 \xe2\x80\x980v.\'808\'8 PUB \xc2\xa309\'/\xc2\xa59\'8 102G 1SS\'8 \'8Y6\'62S \'8 \'66Y\'L9E\'8 1000\'60S\'8 :\xe2\x82\xac82\'CEL\'0 \'\xc2\xa396\'88F\'9 "SON 1Uled \'S\'N \xe2\x80\x98ainjesay| Buigquosaid Bulfuedwoooe pesy :abesoq [ensn dX3%\xc2\xae 1071 dx3 HSINYVA ON L1071 2L06829SHS2L N/S'
b7d23ac2-e776-9f62-3290-c64c2d6eb353_850_7.jpg b'NDC 59011-277-60 90-815\xe2\x82\xac0\xe2\x82\xac s 09-222-1 _,oom 1\xc2\xa31E-10690 19 \xe2\x80\x98Plojwerg *d"] ewlieyd enpind "(4.98-,69) 0-0\xe2\x82\xac~SGH usamlag pajiwied suoisINoXs ((d,//) 0,62 1e 2101 \xe2\x80\x9cJouleuoo juelsisal-ydi| by e ul ssuadsig Ao = \xe2\x80\x94K o B > 2o g2 | \xc2\xa3 g3 W S5 EE5| 05O = == x \xc2\xa3 2 = m; = Ec2 =g gog| T 32 0w 2385 0w S Iea S - FE iy 2% o9 g=g Q0 < \xc2\xa7g5 T = C oo gf=| , 85 - OO0 s3] & =g v 338 s\xc2\xa35| 3 B3z 00 S22 o] & \xc2\xa9 90 IS5 252| \xc2\xae =353 28 23| \xc2\xa3 8 Es > << (=] o L <% 212385 \xe2\x80\x980v.\'808\'8 PUB \xc2\xa399\'/\xc2\xa59\'8 102G 1SS\'8 \xe2\x80\x988Y6\'62S \'8 \'667\'19E\'8 1090\'60\xe2\x82\xac\'8 \xe2\x80\x98\xe2\x82\xac8L\'EEL\' \'\xc2\xa396\'881\'9 "SON W9led \'S\'N \xe2\x80\x98alnjesay| Buigquosaid Bulfuedwoooe pesy ebesoq [ensn dX3%\xc2\xae LO1 dx3 HSINYVA ON L1071 21060/9\xc2\xa2HETL N/S'
bfdfe235-d717-4855-a3c8-a13d26dadede_267_6.jpg b'B0 e 092 0089 682 P25 9V 21 L TS0 S SON WAk 11 (.88-65) 00839} UaamIsq ponLBd SUOISINXE (4o47) 0.5 I 81015 JouEon yes B0 1 ssuedsy @ odone hydrochloride) extended-elease tablets OxyConti NDC 59011-460-10 {oxyc \xe2\x80\x9c@AOSSIp 10 YSNIO \xe2\x80\x98MY Healq 10 J0U 0( "2[OLM SI9[q 2} MO|[EMG s BLIfLEd1I000E PEsy IXILOT gx3 HSINSYAON | 9q 2L068296%\xc2\xa22L N/S Stmiord, CT 06901-3431 Purdue Pharma LP. 302081-0D Only 100 Tablets Ry'
bfdfe235-d717-4855-a3c8-a13d26dadede_267_7.jpg b'-08%-1106 = 32 BE e (4.98-65) 0,085k Usampq mm & pouLLod SUORINGN (4o /) 3,551 91013 B B & e e esiedsi] \xc2\xa38 & C@ S o S22 \xc2\xa3 8= o = = sESZ ME O 2 =8 < 2 Qo \xc2\xa3 = =5 @ 1Q ks " S P~ o S HSE = 2O 8% 8 \xe2\x80\x9c3AJ0SSIP 10 \xe2\x80\x9cYSIID \xe2\x80\x98WAL Yealq 13 10U 0( "2JOLM SIRIQR) MO|[EMG Bulktiediioooe pesy eBesoq [ensn IXILOT gx3 HSINSYAON | 9q 2L068295%\xc2\xa2\xe2\x82\xac2L N/S'
c38dcd37-9840-4f71-a5c9-97380c8107f2_377_6.jpg b'P T T e, ajeq "dx3 % #107 404 Baly paysiuieaun ww Q) X Gz 921\xc2\xa7 __ 16911 o 12l0L \xe2\x82\xac0-810\xc2\xa2-20 \'Ned "VIANI Ul 8pepy /0880 N \xe2\x80\x98Ielemabpug 977 Sa9ualasolg [eauwy \xe2\x80\x9cAq painguasia 625 1/82/9 0N 211 By \xe2\x80\x98uolpeuLiojul abeI0}s pue abesop o} Hasul 983 :a6eso(] [ens() "UOHRD Ul [eIA 810]G "9)e.Jahl1ja1 10 3zaaly Jou 0( \'|Iam 3)eys *asn |[eaateljul Jo \xe2\x80\x98leanpida \xe2\x80\x9cenaoenui \xe2\x80\x98qj Al 104 10N Rx only lone 1amcino Acetonide Injectable Suspension, USP 400 mg per 10 mL (40 mg per mL) Intra-articular use only 10 mL Multiple-Dose Vial NDC 70121-1169-1 For Intramuscular or Tr'
c38dcd37-9840-4f71-a5c9-97380c8107f2_377_7.jpg b'Space for UPs No. *pajund aq |[eys Xiew ejep gz Wim UOLIRY 4983 U0 "o [e1as anbjun pue dx3 707\xc2\xb0NILY J0 Elep ajqeuieA ] \' NDC 70121-1169-1 \xc2\xa5 Each mL provides 40 mg triamcinolone ! NDC 70121-1169-1 1 Mfg. Lic. No. G/28/1539 \xc2\xa5 \xc2\xa5 acetonide with 0.65% sodium chloride 1 R ! 1 for isotonicity, 0.99% (w/v) benzyl 1 1 V. i 1 = s \xc2\xa5 alcohol added as a preservative, 1 . i 1 Amneal Pharmaceuticals Pvt. 1 Triamcinolone \' 1 Triamcinolone ) Ltd. g i | 0.75% carboxymethyicellulose sodium, ! | Parenteral Unit 1 Acetonide Injectable | ggge%\xe2\x80\x98?:z\xe2\x80\x98:\xe2\x80\x98g;e\'{fs%""a\xe2\x80\x98;\xe2\x80\x99ogm \xef\xac\x81;\xe2\x80\x98 \xe2\x80\x98oige 1 Acetonide Injectable | Amedavad 382213 o Suspension, USP \xc2\xa5 or hydrochioric acid may be presentto 1 Suspension, USP Distributed by: 1 adjust pH10 5.010 7.5. 1 Amneal Biosciences LLC (40 mg per mL) 1 NOT FOR INTRAVENOUS, t (40 mg per mL) Bevil7- 2080 INTRADERMAL, INTRAOCULAR, 1 For lmmnsculav or VEPIDURAL, OR INTRATHECALUSE. ! For Inlv_amuscnlar or 1 \xc2\xa7 Intra-articular use only 1 ) 1 Intra-articular use only 1 1 3 Usual Dosage: See insert for dosage 1 1 1 10 mL Multiple-Dose Vial 3 information. 1 10 mL Multiple-Dose Vial 1 y Read all sides ! Sf\xef\xac\x82le at20\xc2\xb0t0 25\xc2\xb0C (68\xc2\xb0t0 77\xc2\xb0F) ! Read all sides ! ! [see USP Controlled Room \' \xc2\xa5 ! Tempelalure], do not refrigerate, ! \xc2\xa5 X avold freezing and protect from light. ! Ty Rx only Stnle vial in carton. : 370121711691 Triamcinolone Acetonide Injectable Suspension, USP E T L (40 mg per mL) For Intramuscular or Intra-articular use only 10 mL Multiple-Dose Vial P'
c548b645-0a3c-436e-9a62-0f5fd295efca_228_6.jpg b'BENZTROPINE BENZTROPINE. BESEROr wor g 1 BEVENERMEr uoe 2mg 3E2mg et \xc2\xa3 | st 33 Wttt BENZTROPINE aenzTROPINE BENIRONE e vee o PEVONOTNEr uee 2mg 5E fx iy e il BENZTROPINE BENZTROPINE RENIROT e use o 3 RESVOMETANCET. Use B 5\xc2\xa7 frim fr il Oneseesrarety % F &= @nomsmsTaretit BENZTROPINE. BENZTROPINE SENIRORNE ver g 1, SESIROTANEer v g 5E i g i3 it I el i, g 5o DHLWTN BENZTROPINE BENZTROPINE DENIROPNEr use s BENVDROREer se e 58 i i 22 bedtasin s i Esl s tts %5 55 o otuamaran h'
c90cdf38-2b2a-4d8c-a7b5-373787173193_345_6.jpg b'BENZTROPINE BENZTROPINE. BESEROr wor g 1 BEVENERMEr uoe 2mg 3E2mg et \xc2\xa3 | st 33 Wttt BENZTROPINE aenzTROPINE BENIRONE e vee o PEVONOTNEr uee 2mg 5E fx iy e il BENZTROPINE BENZTROPINE RENIROT e use o 3 RESVOMETANCET. Use B 5\xc2\xa7 frim fr il Oneseesrarety % F &= @nomsmsTaretit BENZTROPINE. BENZTROPINE SENIRORNE ver g 1, SESIROTANEer v g 5E i g i3 it I el i, g 5o DHLWTN BENZTROPINE BENZTROPINE DENIROPNEr use s BENVDROREer se e 58 i i 22 bedtasin s i Esl s tts %5 55 o otuamaran h'
cc5e1c44-79e9-45d3-b1e5-b003f550c508_31_6.jpg b"sejnsdeg esop-un (01 X 8) 08 dsn sajnsdeq auopiseidiz = Over Pinting Zone: (Dotted fnes rotto e print) 'UNVARNISH ZONE \xe2\x80\x94 - Ziprasidone Capsules USP Usual Dosage: See accompanying prescribing information. Store at 20\xc2\xb0 to 25\xc2\xb0C (68\xc2\xb0 to 77\xc2\xb0F) [see USP Controlled Room Temperature]. This unit-dose package s not child resistant. I dispensed for outpatient use, a child resistant container should be used. WS 5! 7nun|||| seenid Ziprasidone Capsules USP Each capsule contains: Ziprasidone hycrochloride USP equivalent to 60 mg ziprasidone. 80 (8 x10) Unit-dose Capsules NDC 65862-704-80 Rx only Ziprasidone Capsules US /2 AUROBINDO 80 (8 x 10) Unit-dose Capsules Ziprasidone Capsules USP Rt vop 1. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India 80 (8.x 10) Unit-dose Capsules Code: TS/DRUGS/22/2009"
cc5e1c44-79e9-45d3-b1e5-b003f550c508_31_7.jpg b'NDC 65862-705-60 Rx only Ziprasidone Capsules USP @ somgC /2 AUROBINDO 60 Capsules Each capsule contains: Ziprasidone hydrochloride USP equivalent to 80 mg ziprasidone. Usual Dosage: See accompanying prescribing information. Store at 20\xc2\xb0 to 25\xc2\xb0C (68\xc2\xb0 to 77\xc2\xb0F) [see USP Controlled Room Temperature]. Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India Code: TS/DRUGS/22/2009 P1421736 *Over printing Zone Coding Area 4515 mm) Dot s ot o be pirted'
cc5e1c44-79e9-45d3-b1e5-b003f550c508_31_8.jpg b"i i ! Ziprasidone Capsules USP e Dage: e oo e vt S 20525 (51079t US et R Tt i g il s e, i ki i e Ziprasidone Cai:ul!: usp Ech apl oo s oot P el 1) Ssidon. 00210 Ui o J '\\ / NDC 65862-705-80 Rx only Ziprasidone Capsules USP - a /9 auonoo 80 (8 x10) Unit-dose Capsules Ziprasidone Capsules USP pabustr | 27 s ot o Ein WVt Moot 08210 Unicdor Cpaies ot TSI"
d58f1f63-4bb6-413c-9730-ded3e8078618_829_10.jpg b'/1000 Tablets NDC 72205-004-99\xe2\x80\x98 Rosuvastatin Calcium Tablets Rx Only NOVADOZ A \xe2\x80\x9cEach tablet contains rosuvastatin calcium Manufactured by: equivalent to 20 mg of rosuvastatin. MSN Laboratories Private Limited, USUAL DOSAGE: Telangana - 509 216, INDIA. See accompanying Prescribing information. Distributed by: WARNING: Novadoz Pharmaceuticals LLC As with all medications, keep out of the Flasaawey i Qodbt-5114 reach of children. 855 - NOVADOZ 668-2369 Store at controlled room temperature, 20-25\xc2\xb0C (68-77\xc2\xb0F) [see USP Controlled Issued: 04/2018 Room Temperature]. Protect from moisture. - -\xc2\xab - -\xc2\xab -eememmamnmnnniia s M.L.No.: 5/MN/TS/2014/F/G N || sili72205l004991 M3 J/ D07270-00 LOT : XXXXXXXXXX _> EXP : MM/YYYY LOT & EXP Details along with variable data shall be Over coded during packing. Coding area 46x30 mm'
d58f1f63-4bb6-413c-9730-ded3e8078618_829_16.jpg b'sjo|qeL wnioje) uljeISeANSOY fwon RxOnly NDC 72205.005-06 Rosuvastatin Calcium Tablets 100 (10X 10) Uni-dose Tablets NOVADOZ Each bt contins roswastatincacum oquhalet 1 40 mg o osuvastan USUAL DOSAGE: \xe2\x80\x98Son sccompanying Proscribig normatin. WARNNG: As i al madicatons, keep oul of e resch of . Store st conroed oo rperatrs, 2025\xc2\xb0C (6677\xc2\xb0F) [sea USP Cortrobad Room Temperatire]. Prtect from molstut o%00006\xc2\xa2 MLNo: SMNTS2014F /6. |\\ RxOnly voc 120500500 Rosuvastatin Calcium Tablets 100 (10X 10)Unit-dose Tbiets Manutactured by: VSN Laborares Prvat Linied, Tolangana - 509215, NDIA. Ditrbtacby: Novados Pharmacauticals LLC Patanay, NJ088543714 B5-NOVADOZ e Issut: 042018'
d58f1f63-4bb6-413c-9730-ded3e8078618_829_17.jpg b'Rosuvastatin Calcium Tablet NDC 72205-005-11 Store at 20-25\xc2\xb0C (68-77\xc2\xb0F) Protect from moisture. VSN Laboratories Prvete Limited Made in India Lot \xc2\xa3 Rosuvastatin Calcium Tablet NDC 72205-005-11 Store at 20-25\xc2\xb0C (68-77\xc2\xb0F) Protect from moisture. MSN Laboratores Prvate Limited Made in India Lot Rosuvastatin Calcium Tablet NDC 72205-005-11 Store at 20-25\xc2\xb0C (68-77\xc2\xb0F) Protect from moisture. MSN Laboratories Prvate Limited Made in India Lot Rosuvastatin Calcium Tablet NDC 72205-005-11 Store at 20-25\xc2\xb0C (68-77\xc2\xb0F) Protect from moisture. MSN Laboratories Prvate Limited Made in India Lot Rosuvastatin Calcium Tablet NDC 72205-005-11 Store at 20-25\xc2\xb0C (68-77\xc2\xb0F) Protect from moisture. MSN Laboratores Private Limited Made in India Lot \xc2\xa3 2 00511 Rosuvastatin Calcium Tablet NDC 72205-005-11 Store at 20-25\xc2\xb0C (68-77\xc2\xb0F) Protect from moisture MSN Laboratores Private Limited Made in India Lot Exp. Rosuvastatin Calcium Tablet D NDC 72205-005-11 Store at 20-25\xc2\xb0C (68-77\xc2\xb0F) Protect from moisture MSN Laboratores Private Limited Made in India Lot Rosuvastatin Calcium Tablet NDC 72205.005-11 Store at 20-25\xc2\xb0C (68-77\xc2\xb0F) Protect from moisture MSN Laboratores Private Linited Made in India Lot Rosuvastatin Calcium Tablet @ NDC 72205-005-11 Store at 20-25\xc2\xb0C (68-77\xc2\xb0F) Protect from moisture MSN Laboratores Private Limited Made in India Lot Rosuvastatin Calcium Tablet ~ NDC 72205-005-11 \xe2\x80\x94 Store at 20-25\xc2\xb0C (68-77\xc2\xb0F) iy Protect from moisture. MSN Laboratores Private Limited Made in India Lot By M.LNo.: SMNITS/2014/FIG. e, | -'
d58f1f63-4bb6-413c-9730-ded3e8078618_829_6.jpg b'/1000 Tablets NDC 72205-003-99 *Each tablet contains rosuvastatin calcium M.L.No.: 5/MN/TS/2014/FIG equivalent to 10 mg of rosuvastatin. Manufactured by: USUAL DOSAGE: MSN Laboratories Private Limited, See accompanying Prescribing information, 1elangana - 509 216, INDIA. Distributed by: 2 . T ROS uvastatl n XvsAm:![!\xef\xac\x81nedications, keep out of the reach NavadozEharmacedticals LLC of children. Piscataway, NJ 08854-3714 C a I ci u m Ta b Iets Store at controlled room temperature, 835 26%\\-,2%[;22 20-25\xc2\xb0C (68-77\xc2\xb0F) [see USP Controlled peemmt e m e s s a . ) Room Temperature]. Protect from moisture. NOVADOZ y ||| |||| || Issued: 04/2018 72205100399 D07269-00 LOT : XXXXXXXXXX EXP : MM/YYYY LOT & EXP Details along with variable data shall be Over coded during packing. Coding area 42x30 mm'
d58f1f63-4bb6-413c-9730-ded3e8078618_829_7.jpg b'R Only NDC 72205-003-06 Rosuvastatin Calcium Tablets 100 (10X 10) Unit-dose Tablets NOVADOZ *Each tablot contans s uvastatn cacium equivalent 0 10 mg of rosuvastatin UI" i USUAL DOSAGE: Seo acoompanying Prescrbing information. WARNING: s with all medicatons, keep out of the reach of children. X000 Store at controlled room temperature, 20-25\xc2\xb0C (68-77\xc2\xb0F) [soe USP Contraled Room Temperature]. Potect rom mosture. M.LNo: SMNTS?2014/F/G : Q= _; Do Mbcmasnom\xe2\x80\x9c i 28 g . : g \xc2\xa3 Rosuvastatin Calcium Tablets * o0 : &gt 10 mg\xe2\x80\x99] 2 25 & . N F(ll\xe2\x80\x98 g 100 (10 X 10) Unit-dose Tablets Manufactured by: MSN Laboratorics Private Linied, Telangana - 509216, INDIA. Distrbuted by: Novadoz Pharmaceuticals LLC Piscataway, NJ 08854-3714 M| 855- NOVADOZ 682360 Issued: 042018'
d58f1f63-4bb6-413c-9730-ded3e8078618_829_8.jpg b'Rosuvastatin Calcium Tablet @& NDC 72205-003-11 Store at20-25\xc2\xb0C (68-77\xc2\xb0F) Protect from moisture. MSN Laboratories Private Liited Made in India Lot: Rosuvastatin Calcium Tablet NDC 72205-003-11 Store at 20-25\xc2\xb0C (68-77\xc2\xb0F) Protect from moisture. MSN Laboralories Privale Limiled Made in India Lot Ex. Rosuvastatin Calcium Tablet NDC 72205-003-11 Store at20-25\xc2\xb0C (68-77\xc2\xb0F) Protect from moisture. MSN Laboratories Privae Limited Made in India Lot Exp Rosuvastatin Calcium Tablet @D NDC 72205-003-11 Store at20-25\xc2\xb0C (68-77\xc2\xb0F) Protect from moisture. MSN Laboralories Privle Limiled Made in India Lot Exp. Rosuvastatin Calcium Tablet NDC 72205-003-11 Store at 20-25\xc2\xb0C (68-77\xc2\xb0F) Protect from moisture. MSN Laboralories Privale Limiled Made in India Lot Exp. Rosuvastatin Calcium Tablet @ NDC 72205-003-11 Store at 20-25\xc2\xb0C (68-77\xc2\xb0F) Protect from moisture. MSN Laboratories Prvate Limited Made in India Lot: En Rosuvastatin Calcium Tablet NDC 72205-003-11 Store at 20-25\xc2\xb0C (68-77\xc2\xb0F) Protect from moisture. MSN Laboratories Privale Limited Made in India Lot Ex. Rosuvastatin Calcium Tablet NDC 72205-003-11 Store at 20-25\xc2\xb0C (68-77\xc2\xb0F) Protect from moisture. MSN Laboratories Private Limited Made in India Lot Ex. Rosuvastatin Calcium Tablet @D = NDC 72205-00311 Store at 20-25\xc2\xb0C (68-77\xc2\xb0F) Protect from moisture. = MSN Laboratores Private Linited Made in India Lot Exp Rosuvastatin Calcium Tablet NDC 72205-003-11 Store at 20-25\xc2\xb0C (68-77\xc2\xb0F) Protect from moisture. MSN Laboratories Privale Linited Made in India Lot: ) M.LNo: SMNITSI2014/FIG e ! e'
d58f1f63-4bb6-413c-9730-ded3e8078618_829_9.jpg b"USUAL DOSAGE: D07250-00 See accompanying Prescribing information. ROS Uvastati n JURKNG: Is\xc2\xbbsued- 0412018 silli72205 As with all medications, keep out of the reach of children. . ; : Calcium Tablets sem=mes, Room Temperature]. Profect from moisture. *Each tablet contains rosuvastatin M.L.No.: 5IMNITSI2014/FIG 90 Tablets NDC 72205'004'90 calcium equivalent to 20 mg of rosuvastatin. \xe2\x80\x98| | | || | N 00490 Manufactured by: ' LOT : XXXXXXXXXX MSN Laboratories Private Limited, EXP : MMM.YYYY olangana =509 21GHINDIA: 4 > LOT & EXP Details along with variable Distributed by: . data shall be Over coded during packing. Novadoz Pharmaceuticals LLC Piscataway, NJ 08854-3714 855- NOVADOZ : P Coding area 46x25 mm 668-2369 : Rx Only NOVADOZ"
d893e45b-7f18-4c67-b10c-1e2e52a6b3ef_258_6.jpg b'NDC 0338-1915-41 Code 2G3539 O PSS NDC 0335101541 Code 2G3539 O TS GALAXY contaner st Nongyrogenic 4150t onan: Crchi S a2 0 v aorox 200 g of s oo, G5 s 1 st csmoaty ad 50 10 SO0 ki Hyarus, USF adsd a 3. i e W ycHO1c aci 4 ey e o austod Wi sodum Ty, P 55 (01 8.5 Dosage: vl s el by pysican. Sea nsa Gautions: Donotadd cupplomsntary medcaton. Mustotbs s34 n s comnoctns. cck o it Ty gt T o Y. 1 0 31 oun, CATS 35 1) Ty 08 g 0o ot LS8 Sl B . R A GALAXY Gortaner St Hopyrogeic 2 50 i conlans: OacinSofim squalent o 20 Oacln Wi pprox. 300 g of Daiross ydrous, 05 a0 s s oty and S0 o Sagu G syotos, Uk a3 3 b1 asad Wi Y Gy v boan S0l WA S RYGoXGe. PR 05 B0 6] Dosag: nvnousy 2 el by rysiin See e, Gartons: Do ot uppimantary madicaon. Must ot o s n s camnctions. Coce for i T g gt s, 03 ) T 8 g, G'
dd641c7f-b857-48ff-bd9d-747e0c3cc89f_900_6.jpg b'110 s uoweD U ey 708 wor ool \xe2\x80\x9coreni oA 10380 NG Aein 9s0G-0ms weiB Zx01 [en/swesb z dSn \xe2\x80\x9cuonoalu] Joj aundajay rLphgsis 20N NoC 6050561474 Noc s0s0s 1474 o it a sl parrralvoch Manutacurod Cefepime oo o B . i Eacn v o so cep ity e ytocbran, USPcquvaent 02 s amiacure o i o e or 4 Sooun & 2 grams/vial ausment. eston i, Ush 35326 s Dosag: Saopackgs o Rovonts 102 gram Single-Dose Vials I the ay it sore a1 20710 25\xc2\xb0C oo rumne ULTONC. Diue betore ravenous busiors (6810777 (800 USP Conrolled Dt ators ravanous bnfusion, Proactfom Lign. Retinn Caton Ut Tumsof Use. Room Temparsirsd e et U T of st for Injection, USP'
de212757-4232-40e6-b7a2-f5f03251e1b1_304_6.jpg b'@ I Each tablet contains Phenabarbitaf, USP..... . 324mg NDC 69336-116-11 "WARNING: May be habit forming. Ph ba Ibita I, USUAL DOSAGE: See package insert eno DISPENSE in a well-closed container as defined in the Use Tablets, USP STORE at 20\xc2\xb0to 25\xc2\xb0C (68\xc2\xb0 to 77\xc2\xb0F) [see USP s e @ Manufactured for: Sterling | Knight Pharmaceuticals, LLC Ripley, MS 38663 *WARNING: May be habit forming. KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN LotNo: Exp. Date LB871:08-5KP. R1808 1000 TABLETS RxOnly'
de212757-4232-40e6-b7a2-f5f03251e1b1_304_7.jpg b'Phenobarbital\xc2\xae, USP. "WARNING: May USUAL DOSAGE: Sce package insert DISPENSE in a well-closed container as defined in the USP STORE a1 20\xc2\xb010 25\xc2\xb0C (68\xc2\xb0 10 77\xc2\xb0 ) [se0 USP Controled Room Temperature], Manufactured for: Stering | Knight Pharmaceuticals, LLG Ripley, MS 38663 KEEP THIS AND ALL MEDICATION OUT OF THE REACH \xe2\x80\x98OF CHILDREN @ R Ll NDC 69336-117-11 Phenobarbital Tablets, USP e *WARNING: May be habit forming. 1000 TABLETS'
de212757-4232-40e6-b7a2-f5f03251e1b1_304_8.jpg b'@ Bl NDC 69336-118-11 Phenobarbital Tablets, USP DISPENSE in a wel-closed container as defined in the USP STORE 2t 20\xc2\xb0t0 25\xc2\xb0C (68" 10 77\xc2\xb0F) [see USP Controled Room Temperaturs). ml IV Manufactured for: Stering| Knight Phamaceuticals, LLC Ripley. MS 38663 KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN \xe2\x80\x9cWARNING: May be habit forming. 1000 TABLETS'
e13f05f1-7d21-49bb-b8d5-24bf9301c3d7_193_6.jpg b'NDC 0115-1694-30 epinephrine injection, USP auto-inlector FOR ALLERGIC EMERGENCIES In patients weighing over 66 Ibs lmpax Rev. 07/2016 1879-01'
e45c75dc-d381-475b-b649-a871c8a36e60_791_6.jpg b'DESCRIPTION: Each NDC 0527-4584-37 Store at 25\xc2\xb0C (77\xc2\xb0F); extended-elease capsule excursions permitted fo antis 60y f 155 30\xc2\xb0 (59\xc2\xb0- 86\xc2\xb0F) mefhylphenidafe " Il [See USP Controlled fydrochloide. Methylphenidate H(l Room Termperature]. USUAL DOSAGE: See Extended-Relense Capsules CD Keep out of the package circular. Do not reach of children. chew or crush the tu\xef\xac\x81m\\ex m or the beads fnside the capsule. A Medication Guide is required for every prescription dispensed. Please use accompanying Medication Guide. & o Distbuted by: R 1) =z 5 Iy \xc2\xa3 8 ot Compory e, g - Phiadeltin, P 19154 100, CAR3LES 2 2'
e4682a6e-9624-48b0-978f-95da00cfb78f_556_6.jpg b'5 = ES 3 = sz S oo _ =2E S TSwn m..mm S \xc2\xae\xc2\xa9u\'= ap S =" W= ~ == = N Fc w = \xc2\xa9o QLC @< I N = o= \xe2\x80\x94 ZE Hh B N =D bs S 8cl\xc2\xaeg o3 S =mcovo o= 3z g Eo>co &2 =2 <M ILTO~ Tk Each capsule contains amlodipine besylate, USP equivalent to 10 mg amlodipine and 40 mg benazepril hydrochloride, USP. Usual Dosage: See package insert for full prescribing information. Store at 20\xc2\xb0 to 25\xc2\xb0C (68\xc2\xb0 to 77\xc2\xb0F) [See USP Controlled Room Temperature]. Protect from light and moisture. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD. Jerusalem, 9777402, Israel Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 0093-7671-01 N 3 B only Rev. F 1/2015 323K301960215 100 CAPSULES'
e6e34c18-fbc6-4cab-9aed-0905d93c2ab6_291_10.jpg b'T A enpone it oo Etonded o Tabets'
e6e34c18-fbc6-4cab-9aed-0905d93c2ab6_291_6.jpg b'A I'
e6e34c18-fbc6-4cab-9aed-0905d93c2ab6_291_7.jpg b'oo 815 a OOty NDCEHEIBISE GOt Wellegesepnpren | Twice-A-Day (every 12hours) e amepsbegn Bt Opana \xc2\xa3R Sz oores (0Xymorphone hydrochloride) pmRau AT Extended-Release Tablels Diprsiatipt gt s artinens el S et v e Rt U amcenasi Digense hcsampann et 55 HEHo SaeeToton by aesciintcrerg Fai e i wony @eNdo, Uniarrished e'
e6e34c18-fbc6-4cab-9aed-0905d93c2ab6_291_8.jpg b'\\MHMWIH v o oy 1) Opana\xe2\x80\x99 \xc2\xa3R (comaghan ytociids) @ Hg Etenced Rnase Tabets ml A L s'
e6e34c18-fbc6-4cab-9aed-0905d93c2ab6_291_9.jpg b'Bt e Gymonhnelyindiite. omg "D 6348181660 E0tablets Ui piageivan Twice-A-Day (every 12 hours) orcmgiae psaing omstun e e ODANQ\xc2\xae ER (hewed, (nshed, or Dissolved. Sws 2 eorsws (0Xymorphone hydrochloride) St 54 5 ) 5 iy Extendod-Release Tablets T s 20mg g st o ramacedtas b, e et 55 7 e icumg Hiicion Gade 0otk e nony @endo, i & 5'
e7b88a48-12b3-461d-b356-0d7ae4e8fd44_388_6.jpg b'NDC 65862-557-30 Rx only Minocycline Hydrochloride Extended-Release Tabhlets, USP /52 AUROBINDO 30 Tablets *Each extended-release tablet contains: Distributed by: Minocycline hydrochloride, USP equivalent to Aurobindo Pharma USA, Inc. minocycline 115 mg. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Usual Adult Dosage: See package insert. Made in India KEEP THIS AND ALL MEDICATIONS OUT OF Code: TS/DRUGS/22/2009 REACH OF CHILDREN. 80\xc2\xa3.6529859EN Store at 20\xc2\xb0 to 25\xc2\xb0C (68\xc2\xb0 to 77\xc2\xb0F). [See USP , -~ _________ B e Controlled Room Temperature.] Dispense in tight, light-resistant containers as defined in the USP. Protect from light, moisture, and excessive heat. *Qver Printing Zone Coding Area (45x15 mm) Dotted lines not to be printed'
e7b88a48-12b3-461d-b356-0d7ae4e8fd44_388_7.jpg b'*Each extended:-release tablet contains: Distributed by: NDC 65862-558-30 Minocycline hydrochloride, USP Aurobindo Pharma USA, Inc. equivalent to minocycline 135 mg. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Usual Adult Dosage: See package insert. Rx only o Made in India i " : KEEP THIS AND ALL MEDICATIONS Minocycline Hydrochloride OUT OF REACH OF CHILDREN, Co0% TS/DRUGS/22/2009 Extended-Release Tablets, USP = 7 S (R B USP Gortrolled Room Temperature] 2= = == =S TS T oo o s mmmm oo \xc2\xa5 1 Dispense in tight, light-resistant | containers as defined in the USP. ! 1 1 1 S0\xc2\xa385529859EN s Protect from light, moisture, and /52 AUROBINDO 30 Tablets excessive heat. *Over Printing Zone Coding Area (45x 15 mm)'
ec9b5a9c-8caf-4f9b-8c1b-209b2de556dc_820_6.jpg b'z I 3 50458-397-60 4 SeluRdUIOD [E0lINedEULIEU USSSUET 5002 O| Jeduse] woog| 1698-065) 0,0\xe2\x82\xac-o51 | ) paijied SUOIINOKS {[.7/) .52 12 SM0IS| ~ainiesal| onpoid buiAueduicae 558 rabesoq Ao xy : Q 3 5 2 2 " - 3B g y s 2z 8 = =.5 S W i3 2 SS SE\xc2\xa7 NS 558 e NE 55~ w = 3 am D353 \xc2\xa7 = \xe2\x82\xac sEa 4 & S \xc2\xa3 2 c gs\xc2\xa7 & 3 \xc2\xa7 o 3\xc2\xa2 5 00580 PN \xe2\x80\x98SiAsniL g s 8\xc2\xa3/00 d \'oqeing)| B e bR jo onposd| 101 aa NS $09.6E8SPOSE00 NUD | Lt 2/'
ec9b5a9c-8caf-4f9b-8c1b-209b2de556dc_820_7.jpg b'4 750458-398-60 1 solueduon [eopneseULRYY pegonuo) dsi e 0} pajuiad suofsinax . . g g & 8 2 Q 3 v i 8 ] 3 8 g 5 g s 2,z o = 89 o \xef\xac\x82u./ 2Es \xc2\xa2 GE H @ ZW, \xc2\xa385 M~ EC] \xc2\xa3 FRES el f S sg 2 3 S, \xc2\xa2 S @ i 1200k o) OT1 oyu Usssuer Aa Byl uinbpeg o 1onpoid| LO9BEEBSYOSEND NLIO'
f4b2b88c-946c-4670-8538-84f858b7af33_429_6.jpg b"GiiZIDE GipiZIDE DG rosso Tt =1 % 5 SkoaGoaroloaso Tkt oy R s \xc2\xa7q 25 pnt \xc2\xa5 \xc2\xa3l (07) 003 68084 11211 9 \xc2\xa5 @~ @onoosssoes 211 cipzpe cipape IO cessoTablet \xc2\xa3 F 5 AR caase Tabiot 10 mg g \xc2\xa7 \xc2\xa7 10mg \xc2\xa2 R 1 \xc2\xa5 & 1 5% gr sl lotsoatoaarizris EE 53 onomsmmeniznns cippe spzpe S reemse ot @ % brdairiens Tabet Soma 2\xc2\xa7 \xc2\xa7p%ome I B sl 0 o ga0ea 112115, & 83 ohovsanniizno aipzE sipizpe SR oo Tobet \xc2\xa3 3 ARGl Tablet o mo 2\xc2\xa7 \xc2\xa7\xc2\xa7'ome \xe2\x80\x94 \xc2\xa7\xc2\xa7 3 (o) aus s 1211 5 83 oyt gipzE aipzpe SN esse Tavet @ % SAbREreesse Tt i 5\xc2\xa7 %3 Tt \xc2\xa3 5 MR"
f7e9a4b3-a2ee-4f0a-becd-6ef90867332b_675_6.jpg b'5 A QIHSINYVANN VIV dX3 B 101 ___f__u\xe2\x80\x94_r __ _(_ _ m L 9102/LL \xe2\x80\x9cnay 50-5801 weoug 3 des sapun 633 s o o Buunduiosos 25 3000 NS spad s papuas 2 s Suydio B gg susy mm@ \xc2\xa3 (3 MEP wmm _S3a i3 5 wed 22 T 0B 3% 8B i s w \xc2\xa32F O 2 3 EEERE 525 g S%&o EESS \xc2\xa3 SwUw iE&S i \xe2\x80\x98\\l'
f7e9a4b3-a2ee-4f0a-becd-6ef90867332b_675_7.jpg b'QIHSINYVANND VAU X3 B 107 SLLO 9102/1L \xe2\x80\x9cA3y 50-956 2 (R \xc2\xa7 mm@m@ \xc2\xa7 \xc2\xa39p 5 E 38 W B2 52 3g8 i g5 ev, i3 SESES0 nE: & w=5ERSE 2f 2 \xef\xac\x81eman e gz 5\xc2\xa5do 2228 Sz 9%xrmo EE So 2EEEWU = EEES'
f8d16c85-50e2-4d99-afae-6fb902734e42_662_6.jpg b'EAGH TABLET CONTAMS: Lisinoprd, USP. T NDC43547419-10 Reonly | USUAL DOSAGE: S package nset. 5 WARNING: Keep this and al drugs Once-Daily outofreach o niren, S . Depere ma ot coname. Lisinopril STORE 2t 20\xc2\xb0 t025\xc2\xb0C (68\xc2\xb0 0 TT\xc2\xb0F) Tablets, USP see USP Contrlled Room Temperatre] Protect from mosture, freezing and excessive heat. Manufactred by i S R FER0G olco\xe2\x80\x9d 0404702 g\xef\xac\x81\xe2\x80\x9c\xe2\x80\x99_ 100 Tablets'
fbbab179-d1eb-48a6-8e2b-1c71606fe50d_407_6.jpg b'e bt'
fbbab179-d1eb-48a6-8e2b-1c71606fe50d_407_7.jpg b'e Carvedilol Tablets, USP \xc2\xa2 [ Carvedilol g Tablets, USP C [ ] Each i oxas et o Caetio e 20y sl Gntage: S xngonyi o o e et SO ar20\xc2\xb0T 26 6 077 a8 00 ontaned hoom ayeiate] Pt fomgitan moistre. ConeDLPIREN AT ManuBeuRar: oyt Pt 1 Mo 25508 LS5 ek e [MMylan\xe2\x80\x99 [iencon st e'
fbbab179-d1eb-48a6-8e2b-1c71606fe50d_407_8.jpg b'e bt'
